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Abstract
Regulatory T (Treg) cells suppress CD4+ T cell responses during homeostasis and inflammation to
prevent autoimmunity and other immune disorders. Although the transcriptional and epigenetic programs
impacting Treg cell function have been extensively studied, the signaling and metabolic pathways
underlying Treg stability and function are not fully understood. In this study, we determined the role of the
phosphatase PTEN in Treg cells. We found that specific depletion of PTEN in Treg cells results in
excessive TH1 and T follicular helper cells (TFH) responses, associated with elevated germinal center
(GC) B cells and spontaneous development of autoimmune and lymphoproliferative disease in vivo.
Interestingly, the exaggerated TFH and GC responses and autoimmune symptoms are suppressed when
IFN-γ expression is abrogated in mice containing Pten-deficient Treg cells. Thus, the uncontrolled
TH1-mediated inflammation in these mice drives aberrant TFH responses and autoimmune and
lymphoproliferative disease. Mechanistically, we linked PTEN to mTORC2-mediated control of
transcriptional and metabolic programs that enforce Treg cell stability and function. Consistent with this
notion, deletion of Rictor, the obligate component for mTORC2, restores Treg cell function and stability in
the absence of Pten. Similarly, partially restoring the activity of Foxo1, a downstream transcription factor
negatively regulated by mTORC2 signaling, also largely rectified the defects of PTEN-deficient Treg cells.
Together, these results establish that Treg cells rely on the PTEN-mTORC2-Foxo1 axis to maintain their
stability and suppressive activity in controlling TH1 and TFH cell responses.
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ABSTRACT
Regulatory T (Treg) cells suppress CD4+ T cell responses during homeostasis and
inflammation to prevent autoimmunity and other immune disorders. Although the
transcriptional and epigenetic programs impacting Treg cell function have been
extensively studied, the signaling and metabolic pathways underlying Treg stability and
function are not fully understood. In this study, we determined the role of the phosphatase
PTEN in Treg cells. We found that specific depletion of PTEN in Treg cells results in
excessive TH1 and T follicular helper cells (TFH) responses, associated with elevated
germinal center (GC) B cells and spontaneous development of autoimmune and
lymphoproliferative disease in vivo. Interestingly, the exaggerated TFH and GC responses
and autoimmune symptoms are suppressed when IFN-γ expression is abrogated in mice
containing Pten-deficient Treg cells. Thus, the uncontrolled TH1-mediated inflammation
in these mice drives aberrant TFH responses and autoimmune and lymphoproliferative
disease. Mechanistically, we linked PTEN to mTORC2-mediated control of
transcriptional and metabolic programs that enforce Treg cell stability and function.
Consistent with this notion, deletion of Rictor, the obligate component for mTORC2,
restores Treg cell function and stability in the absence of Pten. Similarly, partially
restoring the activity of Foxo1, a downstream transcription factor negatively regulated by
mTORC2 signaling, also largely rectified the defects of PTEN-deficient Treg cells.
Together, these results establish that Treg cells rely on the PTEN-mTORC2-Foxo1 axis
to maintain their stability and suppressive activity in controlling TH1 and TFH cell
responses.
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CHAPTER 1.

INTRODUCTION

Overview
Regulatory T (Treg) cells, identified as the Foxp3+ subset of CD4+ T cells,
maintain tolerance to self-antigens and prevent autoimmune diseases (Josefowicz et al.,
2012; Tang and Bluestone, 2008). Continuous T cell receptor (TCR) activation is
important for Treg cell function (Levine et al., 2014). TCR signaling activates the
phosphoinositide 3-kinase (PI3K), AKT, and the mechanistic target of rapamycin
(mTOR) pathways. The strength and duration of PI3K, AKT, and mTOR signaling
modulates Foxp3 expression to control Treg cell development or differentiation (Chi,
2012). Further, the level of mTOR signaling also affects the suppressive function of Treg
cells (Park et al., 2013; Wei et al., 2016; Zeng et al., 2013). Phosphatase and tensin
homolog (PTEN, encoded by the Pten gene) is a lipid phosphatase that directly opposes
PI3K signaling by dephosphorylating phosphatidylinositol (3,4,5)-trisphosphate (PIP3) to
generate phosphatidylinositol (3,4)-bisphosphate (PIP2). However, molecular pathways
mediated by PTEN and its role specifically in Treg cells remain to be established.
Therefore, the main goals of our study were the following:
1. Investigate the mechanism by which PTEN signaling controls the homeostasis
and functions of Treg cells.
2. Identify signaling pathways and target genes involved in PTEN-mediated
regulation of Treg cells.
T Cell Development, Homeostasis, and Differentiation
T cells are white blood cells that develop in the thymus from bone marrowderived hematopoietic stem cells (HSCs). Specifically, HSCs differentiate into multipotent progenitors capable of further differentiating into common lymphoid progenitors
that give rise to T cells, B cells, and natural killer cells. Once in the thymus, lymphoid
progenitors lose alternative lineage potential and commit to the T cell fate (Germain,
2002; Yang et al., 2010). The thymic microenvironment provides unique signals to T cell
precursors, causing changes in transcriptional signatures that promote the expression of
functional, antigen-specific TCRs. Ultimately, these precursors undergo TCR positive
and negative selection and finally, they leave thymus to become mature CD4+ or CD8+ T
cells.
Upon egress from thymus, T cells are maintained in a quiescent state. Quiescent T
cells are smaller in cell size and have lower metabolic rates than activated T cells, which
is discussed in greater detail below. Further, they are maintained in the G0 phase of the
cell cycle. Because TCR repertoire diversity is important for recognition of many
pathogens, quiescence may preserve energy to limit the size of the naïve T cell pool
(Yang and Chi, 2012). Several transcription factors, including Krüpple-like factor 2
(KLF2) and Forkhead box protein P1 (Foxp1), are essential for the maintenance of T cell
quiescence (Buckley et al., 2001; Feng et al., 2010). The signaling molecules regulating T
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cell quiescence have also been extensively studied and are discussed in other reviews
(Hamilton and Jameson, 2012; Hua and Thompson, 2001; Yang and Chi, 2012). Below,
we briefly discuss how the mTOR pathway regulates T cell quiescence.
Upon receiving the appropriate activating stimuli, naïve T cells proliferate and
differentiate into effector T cells. These differentiated effector populations are termed
CD4+ T helper (TH) cells and CD8+ cytotoxic T lymphocytes (CTLs). Three activating
signals are required to drive TH and CTL differentiation. Signal 1 is generated by
interaction of TCR with the cognate peptide presented in the context of the major
histocompatibility complex (MHC) molecule (Banchereau and Steinman, 1998). The
second signal is co-stimulation, achieved when CD28 on the T cell engages CD80 and/or
CD86 on the antigen-presenting cell (APC) (Reis e Sousa, 2006). Finally, signal 3 is
cytokine stimulation provided by APCs that function to orchestrate effector T cell
differentiation (Curtsinger and Mescher, 2010). CD4+ cells are involved in serving other
immune cells, such as B cells for antibody production and activation of macrophages to
promote clearance of infectious agents. CD8+ T cells, on the other hand, are directly
involved in killing infected host cells by releasing perforins and granzymes.
Differentiation of Conventional CD4+ T Cells
Naïve CD4+ T cells circulate between the blood and secondary lymphoid organs.
Upon receiving cognate antigen and co-stimulatory signals from APCs, naïve CD4+ T
cells are activated, proliferate, and can further differentiate into effector CD4+ T cells.
The major CD4+ T helper subsets are T helper (TH) 1, TH2, TH17, and T follicular helper
(TFH) cells (Figure 1-1). Cellular function, transcription factors and signature cytokine
profiles characterize these TH subsets. The signals and transcription factors driving TH
subset differentiation are discussed below.
TH1 cells
Early analysis of mouse CD4+ T cell clones established the existence of two
distinct T cell subsets. The first subset, called TH1 cells, predominantly secretes
interferon (IFN)-γ; these cells also produce interleukin (IL)-2 and tumor necrosis factor
alpha (TNF-α) (Mosmann et al., 1986; Zhu et al., 2010). TH1 cells are primarily
responsible for cell-mediated immunity via the activation of macrophages, neutrophils,
and natural killer cells; they also aid CTL differentiation. TH1 cells are known to be
involved in cellular immunity and help eradicate intracellular bacteria; however,
overexpression of IL-12 causes excessive TH1 responses, leading to inflammation and
autoimmune diseases, such as type 1 diabetes, in mice and humans (Szelachowska et al.,
1997; Trembleau et al., 1995; Trembleau et al., 1999). TH1 responses are also known to
be involved in the development of systemic lupus erythematosus (SLE). Elevated IFN-γ
concentrations are detected in SLE patients (Gerez et al., 1997). In mouse models of SLE,
IFN-γ is linked to exacerbated disease development, which can be significantly delayed
using anti-IFN-γ antibody (Jacob et al., 1987). Thus, excessive TH1 responses can play a
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Figure 1-1. Schematic representation of conventional helper T cell diversity.
Naïve CD4+ T cells can differentiate into several different types of helper T cell subsets
depending on cytokines and transcription factors present during activation.
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detrimental role in autoimmune disease development, but how these responses contribute
to disease development are not clear.
In addition to TCR and co-stimulatory signals, IFN-γ and IL-12 play important
roles in helping naïve T cells commit towards TH1 cells. Naïve T cells do not express IL12 receptor inducible chain (IL-12Rβ2), which is required for activation of the signaling
pathway involved in TH1 differentiation. TCR activation induces IL-12Rβ2 expression.
IL-12Rβ2 expression is further stabilized by IFN-γ, allowing IL-12R signaling to
progress and ensure TH1 cell differentiation (Szabo et al., 1997). Mechanistically, IL-12R
signaling is coupled to signal transducer and activator of transcription (STAT) 4
activation, which in turn promotes T-box transcription factor T-bet (encoded by Tbx21)
expression (Szabo, Kim et al. 2000; Zhu, Yamane et al. 2010). It has been shown that Tbet-deficient naïve T cells fail to differentiate into TH1 cells, resulting in enhanced
susceptibility to Leishmania major and other bacterial infections (Ravindran et al., 2005;
Sullivan et al., 2005; Szabo et al., 2002). T-bet regulates the expression of IFN-γ (Szabo
et al., 2000; Zhu et al., 2010). Additionally, T-bet intrinsically suppresses the
differentiation of other TH subsets, which are discussed below. Future studies will
determine how the interplay between different T cell subsets influence TH1 responses in
different disease contexts.
TH2 cells
The second subset identified in early screens of mouse T cell clones was the TH2
population. TH2 responses are important for clearance of extracellular pathogens and
parasites, such as helminths and nematodes (Finkelman et al., 1991; Sher and Coffman,
1992). In addition to producing the signature cytokine IL-4, TH2 cells produce IL-5 and
IL-13 (Nelms et al., 1999; Zhu et al., 2010). TH2 cells also promote B cell antibody classswitching to generate IgG and IgE (Coffman et al., 1988; Killar et al., 1987). However,
TH2-associated cytokines contribute to the induction of asthma and allergy. For instance,
IL-5 causes airway hyperresponsiveness (AHR) (Cho et al., 2004; Foster et al., 1996).
Moreover, excessive IL-4 and IL-5 production is linked to hyper-IgE production,
eosinophil activation, and mast cell growth, which cause tissue injury. IL-13 stimulates
mucus production, ultimately leading to increased airway obstruction (Danahay et al.,
2002; Maddox and Schwartz, 2002). TH2-associated cytokines, therefore, act via several
mechanisms to promote asthma and allergic disease pathologies.
IL-4R signaling via STAT6 and the induction of the transcription factor GATA
binding protein 3 (GATA3) are required for TH2 cell differentiation. GATA3 positively
regulates and maintains TH2 programming by promoting IL-4 expression, by binding to
the IL-5 promoter to regulate its expression, and by supporting the continuous production
of IL-13 (Zhou and Ouyang, 2003; Zhu, 2010). Moreover, TH1 and TH2 differentiation
programs are antagonistic. Stable GATA3 expression inhibits TH1 differentiation, as it
blocks expression of IFN-γ (Lazarevic et al., 2013; Zhu et al., 2004). Additionally, IL-4
antagonizes IL-12Rβ2 expression to block TH1 polarization (Szabo et al., 1997).
Conversely, it has been implicated that T-bet suppresses IL-4 expression (Szabo et al.,
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2000). As TH2 cell-derived cytokines also help limit acute and chronic inflammation
driven by excessive TH1 immune responses, there may be a potential therapeutic role for
these cells in the treatment of TH1-associated diseases.
TH17 cells
In addition to TH1 and TH2 cells, a third major subset of CD4+ TH cells was
identified. TH17 cells help provide host defense against extracellular bacteria and fungi
by recruiting neutrophils and macrophages to infected tissues (Laan et al., 1999). IL-17A,
IL-17F and IL-22 are the signature cytokines produced by TH17 cells (Korn et al., 2009),
Excessive TH17 cell responses play significant roles in organ-specific autoimmunity. For
example, excessive IL-17 levels contribute to joint destruction in a collagen-induced
arthritis mouse model (Lubberts et al., 2002). TH17 responses are also harmful in the
experimental autoimmune encephalomyelitis (EAE) mouse model of multiple sclerosis
(MS) (Langrish et al., 2005), the mechanisms of which are discussed more fully below.
The differentiation of TH17 cells requires the transcription factors, retinoic orphan
receptor (ROR)γt and RORα, which regulate IL-17A and IL-17F production (Korn,
Bettelli et al. 2009). The expression of RORγt is controlled by the combined actions of
the cytokines, transforming growth factor (TGF)-β, IL-6 and IL-21. STAT1 signaling
downstream of IL-6 and IL-21 is critical to support TH17 cell differentiation. Other
transcription factors also stabilize and promote TH17 programming, including interferon
regulatory factor 4 (IRF4) and runt-related transcription factor 1 (RUNX1) (Brustle et al.,
2007; Huber et al., 2008; Zhang et al., 2008). The TH1 differentiation program can also
suppress TH17 differentiation, as T-bet curtails TH17 commitment by inhibiting the
induction of RUNX1-mediated induction of RORγt (Lazarevic et al., 2013). The TH17
program is also strongly antagonized by those inducing Foxp3+ T cells in the periphery,
via mechanisms that involve Foxp3-mediated suppression of RORγt and RORα (Du et
al., 2008; Ivanov et al., 2006; Zhou et al., 2008).
Compared to the other TH subsets, TH17 cells appear to be less stable. The
stability of the TH17 lineage is regulated by the cytokine IL-23 (Stritesky et al., 2008).
IL-23 consists of the p19 and p40 subunits. Mice deficient in p19 and p40 are protected
from EAE (Cua et al., 2003). Additionally, treatment with anti-p19 and anti-p40
antibodies reduces EAE severity (Chen et al., 2006). By contrast, IL-23 overexpression
exacerbates EAE (Langrish, Chen et al. 2005), thereby establishing a critical role for IL23 in TH17-mediated disease pathologies (Awasthi et al., 2009; Thakker et al., 2007). The
ability of IL-23 to promote disease may be linked to pathogenic TH17 cell differentiation.
In adoptive transfer systems, TH17 cells polarized in the presence of TGF-β1 and IL-6
cannot drive EAE development; however, exposure to IL-23 drives autocrine TGF-β3
signaling that promotes TH17 pathogenicity (Lee et al., 2012). Destabilization of the TH17
lineage can also occur under conditions when TGF-β signaling dominates over TH17polarizing proinflammatory cytokines (e.g. IL-6), resulting in the differentiation of
Foxp3+ T cells over TH17 cells (Ivanov et al., 2006).
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TFH cells
TFH cells are a specialized subset of CD4+ T cells that migrate to B cell follicles
and provide signals to B cells, promoting germinal center reactions in secondary
lymphoid organs such as spleen, lymph node and Peyer’s patches (Crotty, 2011; Vinuesa
et al., 2016). Germinal centers (GCs) are important sites for antibody affinity maturation
mediated by B cell clonal expansion and somatic hypermutation. They also serve as sites
for memory and plasma B cell differentiation. The differentiation of TFH cells from naïve
CD4+ T cells requires interactions with dendritic cells (DCs) in T cell areas and with B
cells in B cell follicles and germinal centers, as discussed below. The lineage specific
transcription factors for TFH programming are B-cell lymphoma 6 protein (Bcl6) and
achaete-scute family bHLH transcription factor 2 (Ascl2) (Johnston et al., 2009; Liu et
al., 2014; Nurieva et al., 2009; Yu et al., 2009). TFH cells also are characterized by the
expression of chemokine receptor, CXCR5, co-stimulatory/inhibitory molecules ICOS
and PD-1, and various effector molecules CD154 (also called CD40L), OX40, BTLA and
CD84 (Crotty, 2011; Ma et al., 2012; Vinuesa et al., 2016). IL-21 is the primary cytokine
essential for differentiation of TFH cells (Crotty, 2011; Vinuesa et al., 2016).
Uncontrolled, excessive TFH responses lead to the development of autoimmune
diseases. SLE is among these diseases and is characterized by the production of
autoantibodies (Craft, 2012; Linterman et al., 2009). Additionally, increased TFH
frequencies have been seen in patients infected with human immunodeficiency virus
(HIV) (Cubas et al., 2013; Lindqvist et al., 2012; Perreau et al., 2013). Various cancers,
such as angioimmunoblastic T-cell lymphoma (AITL) and peripheral T-cell lymphomanot otherwise specified (PCTL-NOS), also have increased TFH responses (de Leval et al.,
2007; Dorfman et al., 2006; Dupuis et al., 2006; Huang et al., 2009; Ma and Deenick,
2014). Studies are currently aimed at understanding how TFH responses are exacerbated
in these various diseases.
TFH cell differentiation requires interactions with both dendritic and B cells. Like
other TH subsets, TFH priming is initiated when naïve T cells receive TCR and costimulatory signals from DCs. During priming, ICOS-ICOSL interactions and IL-6R
signaling are essential to support commitment into early-TFH cells (Xu et al., 2013).
These pre-TFH upregulate CXCR5 expression and downregulate CCR7 expression,
allowing them to migrate to the T-B cell border and B cell follicle of secondary lymphoid
tissues. Liu et al. has shown the transcription factor Ascl2 helps in TFH programming by
upregulating CXCR5 and CXCR4 expression, and downregulating CCR7 and PSGL1
expression. As such, Ascl2 expression helps initiate T cell migration to B cell follicles
and suppresses TH1, TH2 and TH17 differentiation (Liu et al., 2014). Further, IL-6
signaling induces B-cell lymphoma 6 protein (Bcl6) expression in pre-TFH cells, and this
transcription factor is essential only for TFH differentiation among the TH subsets
(Johnston et al., 2009; Nurieva et al., 2009; Yu et al., 2009). Additionally, Bcl6 represses
the expression of cytokines and transcription factors essential for TH1, TH2 and TH17
differentiation. In support of this view, transducing CD4+ T cells with a Bcl6-encoding
retrovirus reduced T-bet and GATA3 expression in TH1 and TH2 polarizing conditions,
respectively (Yu et al., 2009). Furthermore, overexpression of Bcl6 also reduces IFN-γ
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and IL-17 production, cytokines associated with the TH1 and TH17 programs, respectively
(Yu et al., 2009).
The second stage of TFH differentiation begins when pre-TFH interact with B cells
localized in T-B cell border or B cell follicle (Crotty, 2014; Vinuesa et al., 2016). B cellpre-TFH interactions can promote differentiation of short-lived plasmablasts, or these
interactions can promote maturation of the GC reactions. GC-associated, mature TFH cells
express higher levels of CXCR5 and Bcl6 than pre-TFH or other activated TH subsets. To
promote mature TFH differentiation, B cells provide antigen and co-stimulatory signals
via ICOS to pre-TFH cells to further drive TFH differentiation. Signaling lymphocyte
activation molecule-associated protein (SAP) promotes TFH and B cells adhesion (Qi et
al., 2008), which is an important process for the differentiation of TFH cells, GC B cells,
memory B cells and plasma cells (Hu et al., 2013). Mechanistically, SAP binds SLAM
family member 6 (SLAMF6), a molecule necessary for TFH function (Kageyama et al.,
2012), and the SAP-SLAM interaction drives IL-4 production by TFH cells. Then, IL-4
and IL-21 derived from TFH promotes GC B cell survival and proliferation (Crotty, 2011;
Vinuesa et al., 2016). IL-21 expressed by TFH and GC B cells also helps in plasma cell
differentiation (Ozaki et al., 2004). In addition to being GC resident cells, mature TFH
also have the capacity to exit the GC, where they can migrate to other B cell follicles or
recirculate as a small population within the bloodstream (Shulman et al., 2013). These
processes have been summarized in Figure 1-2.
Treg Cells
Foxp3 is the master transcription factor of Treg cells
In a seminal study by Sakaguchi and colleagues, the presence of a suppressive
CD4+ T cell subset expressing high levels of CD25 (IL-2 receptor α chain) was identified
(Sakaguchi et al., 1995). These cells appeared to be distinct from effector T cells also
expressing CD25, as their antigen-driven proliferation was less than conventional CD4+ T
cells (Hayashi et al., 2004; Thornton and Shevach, 1998). In experimental systems, the
CD4+CD25+ T cells were found to suppress autoreactive T cells. Further, depletion of
CD4+CD25+ T cells promoted organ-specific autoimmune disease, which was averted by
adoptive transfer of CD4+CD25+ cells. These suppressive T cells are now known as Treg
cells, and they play a central role in the regulation of the immune responses. These
responses include the anti-tumor immunity, autoimmunity, allergic responses, graft-vshost disease, and pathogen-induced immune responses (Josefowicz et al., 2012;
Sakaguchi, 2005; Tang and Bluestone, 2008).
The forkhead/winged helix protein Foxp3 functions as a master regulator of Treg
cell differentiation and is preferentially expressed in CD4+CD25+ T cells in both the
thymus and spleen (Ohkura and Sakaguchi, 2010). The suppressive activity of Treg cells
requires continuous expression of Foxp3 (Williams and Rudensky, 2007).
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Figure 1-2. Multiple signals and differentiation stages are involved in TFH and
germinal center B cell development.
Different inducing factors are necessary for different stages of TFH cell differentiation,
which ultimately help germinal center B cells to produce plasma or memory B cells.
Reprinted with permission. Craft, J.E. (2012). Follicular helper T cells in immunity and
systemic autoimmunity. Nature reviews. Rheumatology 8, 337-347.
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FOXP3 mutations in humans cause a severe multi-organ autoimmune and
inflammatory disorder known as immune dysregulation, polyendocrinopathy,
enteropathy, X-linked (IPEX) syndrome (Bennett and Ochs, 2001). Mutating Foxp3 in
mice also results in X-linked lymphoproliferative disease known as scurfy, which is
attributed to loss of T cell tolerance (Hori et al., 2003).
Studies have indicated forkhead box O (Foxo) family transcription factors are
essential for regulating the expression of Foxp3 and thereby promoting Treg cell
programming (Harada et al., 2010; Kerdiles et al., 2010; Ouyang et al., 2009; Ouyang et
al., 2010; Ouyang et al., 2012). Using T cell specific deletion of Foxo1 and Foxo3,
Ouyang et al. showed that binding of Foxo1 and Foxo3 to the promoter region of Foxp3
regulates Foxp3 expression (Ouyang et al., 2010). Furthermore, Treg-specific deletion of
Foxo1 causes an inflammatory disease (Ouyang et al., 2012). Regulation of these Foxo
factors is tightly controlled by the serine/threonine kinase, AKT (Calnan and Brunet,
2008; Merkenschlager and von Boehmer, 2010). Specifically, AKT-dependent
phosphorylation of Foxo proteins sequesters these proteins in the cytoplasm, preventing
their nuclear functions (Calnan and Brunet, 2008). Interestingly, the balance of Foxo
signaling is a critical determinant of Treg cell function, since mutating the AKT
phosphorylation sites of Foxo1 and thereby driving constitutive Foxo1 function in Treg
cells also drives tissue inflammation (Luo et al., 2016).
Stability of Treg cells
A fundamental issue in immunology is the interplay between effector and
regulatory T cell responses. CD4+Foxp3+ Treg cells regulate inflammatory responses and
play a central role in protecting tissues from damage. Several pathways have been
proposed for Treg cell-mediated control of effector T cell responses, including but not
limited to deprivation of IL-2, secretion of inhibitory cytokines, and modulation of DC
function via cytotoxic T-lymphocyte antigen-4 (CTLA-4) (Sakaguchi et al., 2009;
Vignali et al., 2008). The involvement of a particular mechanism may be contextdependent and may dominate in certain situations.
As noted above, Foxp3 is a crucial transcription factor for Treg cell development
and function. However, recent work has suggested 10-15% of Treg cells may lose Foxp3
expression in certain contexts, resulting in death or instability, the latter forming ex-Treg
cells (Komatsu et al., 2009; Zhou et al., 2009a). These ex-Treg cells no longer express
high levels of Treg cell markers (e.g. CD25, glucocorticoid-induced TNFR-related
protein (GITR), CTLA-4 and are unable to suppress effector T cell proliferation in vitro
(Zhou et al., 2009a). This instability appears to be restricted largely to the
CD25lowFoxp3+ Treg cell population, as this population has been reported to acquire
effector TH cell-like functions (Komatsu et al., 2009). For example, Treg cells can
produce IFN-γ under TH1-polarizing conditions (Dominguez-Villar et al., 2011; Wei et
al., 2009), and these TH1-effector phenotype Treg cells have reduced immunosuppressive
function during an immune response to infection (Oldenhove et al., 2009). However, the
functional consequences of IFN-γ production by Treg cells are still unclear. Studies have
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suggested that IFN-γ production by allogeneic Foxp3+ Treg cells may be beneficial in
preventing experimental graft-versus-host disease (Koenecke et al., 2012), while others
have termed these IFN-γ producing cells as ex-Treg cells that enhance inflammation and
thereby may contribute to autoimmunity (Zhou et al., 2009b). Defining the mechanisms
involved in limiting or enhancing Treg cell stability is crucial to understanding immune
system regulation, functional diversity and fate maintenance of Treg cells. Targeting
these newly discovered mechanisms could provide novel therapeutic applications for
disease intervention.
Heterogeneity of the Foxp3+ Treg cell population
Similar to conventional CD4+ T cells, Treg cells are classified into different
specialized subsets based upon their site of development or expression of surface
molecules. Treg cells arise from the thymus (tTreg cells) or are induced in the periphery
from naïve CD4+ T cells (pTreg cells). In vivo interactions with self- and non-self
antigens lead to the differentiation of tTreg cells and pTreg cells, respectively (Dhamne et
al., 2013; Josefowicz et al., 2012). Naïve T cells can also be polarized into Treg cells in
vitro (iTreg) in the presence of TGF-β and IL-2. These subsets are discussed in greater
detail below.
tTreg cells
tTreg cells differentiate from Foxp3+CD4+ T cell precursors found in the thymus
and comprise 5-10% of peripheral CD4+ T cells. tTreg cells are essential for guarding
against systemic and tissue-specific autoimmunity. In line with this idea, multi-organ
autoimmunity is evident in mice that have undergone neonatal thymectomies (Nishizuka
and Sakakura, 1969). This phenotype is due to the loss of CD4+CD25+ T cells (Asano et
al., 1996), and the development of autoimmunity is inhibited upon transfer of CD4+,
CD4+CD8- or CD25+ T cells (Asano et al., 1996; Fowell and Mason, 1993; Sakaguchi et
al., 1982).
Several signals control tTreg cell differentiation, and these signals appear to be
derived from the thymic medulla (Cowan, Parnell et al. 2013). TCR recognition of MHC
class II-bound peptides is essential for the development of tTreg cells, as CD4+Foxp3+
Treg cells do not develop in the thymus of MHC-II-deficient mice (Fontenot et al., 2005).
CD28 co-stimulation is also essential in tTreg cell differentiation, because tTreg cell
numbers are decreased in CD28, CD80 and CD86 deficient mice (Salomon et al., 2000;
Tai et al., 2005; Zhou et al., 2009). IL-2 is also necessary for the development of tTreg
cells, as IL2R-/- mice failed to generate tTreg cells (Cheng et al., 2013; Cowan et al.,
2013). Additional signals in the periphery, including continuous exposure to selfantigens, IL-2 and TGF-β, are necessary for maintaining stability and function of tTreg
cells (Li et al., 2006; Marie et al., 2005; Marie et al., 2006). Importantly, tTreg cells
express similar phenotypic markers as pTreg cells, such as CTLA-4, GITR and OX40,
but Helios and neuropilin-1 have been suggested as tTreg-specific markers (Dhamne et
al., 2013). Furthermore, epigenetics studies have shown differences in the modifications
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of 5'-C-phosphate-G-3' (CpG) in the Treg-specific demethylated regions (TSDRs) of the
Foxp3 locus between tTreg cells and iTreg cells (Kim et al., 2012; Polansky et al., 2010).
Specifically, the TSDRs in the Foxp3 locus of tTreg cells are mostly demethylated,
whereas iTreg cells have predominately-methylated regions (Floess et al., 2007; Lal and
Bromberg, 2009; Lal et al., 2009; McClymont et al., 2011).
pTreg and iTreg cells
While tTreg cells are major regulators of immune tolerance to self-antigens,
pTreg cells are believed to dampen inflammatory responses to non-self antigens (Dhamne
et al., 2013). For instance, pTreg cells are important for controlling inflammation at
mucosal surfaces (Yadav et al., 2013). It has been reported that pTreg cells are induced in
vivo under low antigenic conditions (Apostolou and von Boehmer, 2004; Kretschmer et
al., 2005; Thorstenson and Khoruts, 2001; Weiss et al., 2012). Similar to tTreg cells,
pTreg cells express canonical markers such as CTLA-4, GITR and CD103. The lack of
specific markers for pTreg cells has limited in vivo analyses of mechanisms driving their
differentiation; so, most studies have analyzed the signals driving iTreg cell
differentiation. IL-2 and TGF-β are required for iTreg cell differentiation from naive
CD4+ T cells (Davidson et al., 2007; Shevach et al., 2008). Further, Foxp3 expression,
survival and suppressive function of iTreg cells are maintained by TGF-β (Nakamura et
al., 2001). Interestingly, iTreg cells have unstable expression of Foxp3 and express a
different gene signature than in vivo Treg cells (Floess et al., 2007). iTreg cells are not as
suppressive and have a more limited transcriptional signature than endogenous Treg cells
(Chen et al., 2003; Fantini et al., 2004; Hill et al., 2007; Wan and Flavell, 2005). Future
studies will advance our understanding of similarities and differences between these Treg
cell subsets.
T follicular regulatory cells
T follicular regulatory (TFR) cells are a GC-resident Treg cell subset that shares
phenotypic features of both tTreg cells and TFH cells. This Treg cell subset expresses
CTLA-4, GITR, Bcl6, ICOS, PD-1 and CXCR5, but are functionally distinct from
conventional populations. Evidence shows TFR cells originate from tTreg cell precursors
(Chung et al., 2011; Crotty, 2011; Linterman et al., 2011; Vinuesa et al., 2016). Bcl6,
SAP, and B cell-deficient mice lack the TFR population, while non-TFR Treg cells are
represented at normal frequencies, convincingly showing that TFR cells are a distinct Treg
cell subset (Chung et al., 2011; Linterman et al., 2011; Wollenberg et al., 2011).
TFR cells in the GC center play a role in suppressing TFH cell and B cell responses,
but the mechanisms for suppression functions remains unclear. Recent studies showed
CTLA-4 regulate TFR cell suppressive function, as the Treg cell-specific deletion of
CTLA-4 in mice leads to increased GC responses (Sage et al., 2014; Wing et al., 2014).
This phenotype is at least partially attributed to diminished TFR function (Sage et al.,
2014). Other means of regulating TFH and GC B cells responses by TFR cells might be
through inhibitory cytokines, such as TGF-β and/or IL-10, as it is known TFH cells are

11

suppressed by TGF-β and antibody production can be altered by IL-10 (Cai et al., 2012;
McCarron and Marie, 2014). The molecular pathways that orchestrate the generation and
function of TFR cells and the interplay with other effector cells remain to be elucidated.
mTOR Signaling Pathway
Rapamycin (also known as sirolimus) is an immunosuppressant drug widely used
to prevent rejection in organ transplantation. The outcomes of studies identifying how
rapamycin mediated its effects lead to the discovery of target of rapamycin 1 (TOR1) and
TOR2 in yeast (Cafferkey et al., 1993; Heitman et al., 1991; Kunz et al., 1993). This
protein is highly conserved across species and is also expressed in mammalian cells
(Chiu et al., 1994; Sabatini et al., 1994; Sabers et al., 1995). The mammalian mechanistic
target of rapamycin (mTOR) is a serine-threonine kinase encoded as a single gene.
mTOR exists in two functionally distinct, multi-protein complexes. mTOR complex 1
(mTORC1) is comprised of mTOR associated with and defined by the presence of the
scaffolding protein Raptor, whereas mTORC2 is associated with and defined by the
scaffolding protein, Rictor (Figure 1-3) (Chi, 2012; Laplante and Sabatini, 2012).
mTORC1 activity is sensitive to rapamycin inhibition while mTORC2 activity is
relatively insensitive to rapamycin, as much higher concentrations or long-term
treatments of rapamycin are required to inhibit mTORC2 activity (Foster and Toschi,
2009).
Regulation of mTOR activity
Immune signals, environmental cues and nutrients are three instructive signals
that activate mTOR signaling pathway and ultimately shape T cell development and
function. There are several regulators upstream of mTOR that help integrate essential
signals, and enhance or inactivate the mTOR activity. One of the key negative regulators
of mTORC1 function is tuberous sclerosis complex (TSC), a heterodimer consisting of
TSC1 (also known as hamartin) and TSC2 (also known as tuberin). Following the
activation of PI3K-AKT pathway by various receptor systems, the TSC complex is
inactivated, subsequently activating mTORC1 function. TSC functions as a GTPase
activating protein for Ras homolog enriched in brain (Rheb), which directly binds to
mTORC1 and has reported roles in driving mTORC1 activity. Rheb needs to be in GTP
bound state to help activate mTOR kinase activity. However, TSC converts Rheb to its
inactive GDP bound form and negatively regulates mTOR (Chi, 2012; Laplante and
Sabatini, 2012) (Figure 1-4). Rheb-deficient T cells have a transient reduction of
TCR/CD28-induced mTORC1 activity (Delgoffe et al., 2009; Yang et al., 2013).
Furthermore, disrupting the TSC1/2 complex by deleting TSC1 upregulates mTORC1
activity (O'Brien et al., 2011; Wu et al., 2011; Yang et al., 2011). However, growth
factors like insulin activate mTORC1 via TSC-independent mechanisms, such as through
the phosphorylation and dissociation of proline-rich AKT substrate of 40-kDa (PRAS40)
from mTORC1. This process inactivates PRAS40 and subsequently activates mTORC1
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Figure 1-3. Schematic diagram showing associated protein components of two
mTOR complexes, mTORC1 and mTORC2.
mTORC1 is comprised of core scaffolding protein mTOR, Raptor, mLST8 and other
associated components PRAS40 and Deptor. mTORC2 consists of core protein mTOR,
Rictor, mLST8 and various associated proteins mSIN1, Protor and Deptor.
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Figure 1-4. mTOR signaling pathway
A serine/threonine protein kinase mTOR helps integrate multiple upstream signals such
as immune signals, environmental cues and nutrients, thereby helping regulate crucial
cell functions downstream such as cell growth, proliferation, survival, protein synthesis
and transcription.
Reprinted with permission. Chi, H. (2012). Regulation and function of mTOR signalling
in T cell fate decisions. Nature reviews. Immunology 12, 325-338. Courtesy of Dr.
Hongbo Chi.
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by allowing it to bind to its substrates (Sancak et al., 2007; Vander Haar et al., 2007;
Wang et al., 2007). Throughout this dissertation, we discuss how upstream inhibitors of
mTOR function control the functions of T cells and Treg cells.
mTORC1 controls multiple downstream functions, including protein and lipid
synthesis, autophagy, cell survival and metabolism. Mechanistically, active mTORC1
promotes translation and protein synthesis by phosphorylating ribosomal protein S6
kinases and eIF4e-binding protein. mTORC1 helps control lipid synthesis, which is
essential for cell proliferation, through sterol regulatory element binding protein 1/2
(SREBP1/2) transcription factors, and stimulates de novo lipid biogenesis through
peroxisome proliferator-activated receptor γ (PPAR-γ) dependent regulation (Laplante
and Sabatini, 2012). mTORC1 inhibits autophagy by phosphorylating unc-51-like kinase
1 (ULK1) (Ganley et al., 2009; Jung et al., 2009). However, there is a complex interplay
between mTORC1 and autophagy, as a recent study from our lab has shown deletion of
genes essential in autophagy resulted in upregulation of mTORC1 promoting defective
Treg cell function (Wei et al., 2016). mTORC1 also orchestrates cellular metabolism by
activating transcription and translation of hypoxia inducible factor 1α (HIF-1α) and cMyc (Wang et al., 2011; Wei et al., 2016; Yang et al., 2013). Cell cycling and survival
are also controlled by mTORC1 via positive regulators such as cyclin D1 and c-Myc
(Gera et al., 2004). Thus, mTORC1 controls many important biological functions.
mTORC2 also plays important roles in cellular biology. mTORC2 is a crucial
regulator of AKT activity via mechanisms discussed below (Sarbassov et al., 2005). In
the absence of mTORC2 function (e.g. Rictor deletion), the AKT-dependent inhibitory
phosphorylation of the Foxo transcription factors is reduced. These transcription factors
are essential for expression of genes involved in cell survival, metabolism and
proliferation (Calnan and Brunet, 2008). AKT is also involved in other cellular
mechanisms, such as cell proliferation and metabolic regulation. Specifically, AKT
promotes cell proliferation by phosphorylation of cell cycle regulatory protein p27 (Shin
et al., 2002), and by indirectly inhibiting the tumor suppressor p53 (Vousden and Lane,
2007). The AKT pathway is also involved in glucose metabolism, as it is known to
translocate glucose transporters such as Glut1 and Glut4 to the cell surface. This process
is essential for promoting glucose metabolism, helping in T cell activation and function
(Bentley et al., 2003; Boxer et al., 2006; Jessen and Goodyear, 2005; Wieman et al.,
2007). Additional downstream targets activated by mTORC2 are protein kinase C (PKC)
isoforms as well as serum- and glucocorticoid-regulated kinase 1 (SGK1) (Figure 1-4),
which in turn regulates cytoskeletal dynamics and ion transport, respectively (Chi, 2012;
Zarogoulidis et al., 2014). Thus, mTORC2 can influence cell survival, proliferation,
growth, differentiation, and trafficking.
mTOR in T helper cell quiescence and differentiation
In addition to maintaining T cell homeostasis, mTOR actively participates in the
highly complex process of T cell differentiation (Figure 1-5). mTORC1 and mTORC2
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Figure 1-5. mTOR signaling controls peripheral T cell fate decisions.
mTOR signaling pathway is involved in promoting differentiation of effector helper T
cell subsets, and inhibits the programming of induced regulatory Treg cells.
Modified with permission. Chapman, N.M., and Chi, H. (2014). mTOR Links
Environmental Signals to T Cell Fate Decisions. Frontiers in immunology 5, 686.
Courtesy of Dr. Nicole Chapman and Dr. Hongbo Chi.
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serve different roles in regulating T cell differentiation and function (Chapman and Chi,
2014). Quiescent naïve T cells have low metabolic and energy demands, which is
correlated with low mTORC1 signaling. Tsc1-/- naïve T cells have excessive mTORC1
activity, which leads to metabolic dysregulation that promotes spontaneous cell growth,
increased cell size, overt cellular activation, and cell proliferation. (O'Brien et al., 2011;
Wu et al., 2011; Yang et al., 2011). Increased apoptotic death induced by TCR
stimulation occurs in Tsc1-/- naïve T cells and is rescued upon anti-apoptotic protein Bcl2
overexpression (Yang et al., 2011). Thus, mTORC1 activity is restrained to regulate T
cell homeostasis.
Furthermore, experiments involving mTOR, Rheb, Raptor and Rictor-deficient T
cells have shown the importance of mTOR signaling pathway in T cell clonal expansion
(Delgoffe et al., 2009; Yang et al., 2013). Loss of Rheb diminishes TH1 and TH17
differentiation, but promotes TH2 polarization (Delgoffe et al., 2011). Absence of RaptormTORC1 signaling results in impaired TH1 or TH2 generation (Yang et al., 2013; Zeng et
al., 2013). In contrast, loss of Rictor-mTORC2 results in defective TH2 but not TH17
differentiation. The role of mTORC2 in TH1 generation is controversial and requires
further investigation (Delgoffe et al., 2011; Lee et al., 2010).
mTOR signaling is also involved in the maintenance and differentiation of CD8+
T cells (Araki et al., 2009; Li et al., 2011). Briefly, deletion of Tsc1 during the late stages
of thymocyte development results in altered CD8+ T cell homeostatic proliferation (Wu et
al., 2011; Yang et al., 2011; Zhang et al., 2012). Loss of Raptor-mTORC1 function
results in impaired effector CD8+ T cell responses in vivo (Yang et al., 2013). Recently,
Pollizzi et al. has linked two different complexes of mTOR, mTORC1 and mTORC2 to
different phases of CD8+ T cell programming. Briefly, Tsc2 deficiency enhances
mTORC1 activity and is associated with terminal differentiation of effector CD8+ T cells
and impaired differentiation into memory CD8+ T cells. Additionally, T cell specific
deletion of Rheb caused inhibition of effector differentiation of CD8+ T cells, while
Rictor-deficient T cells have heightened memory CD8+ T cell differentiation and
responses (Pollizzi et al., 2015). Robust memory CD8+ T cell generation in spleen and
blood upon rapamycin treatment has also been reported, linking mTOR signaling to
CD8+ T cell programming. (Sowell et al., 2014).
mTOR in Treg cell differentiation and function
The presence and magnitude of mTOR signaling also influence Treg cell function.
We recently found that Raptor-mTORC1 signaling is an essential regulator of metabolic
programming necessary for Treg cell function (Yang et al., 2013; Zeng et al., 2013). By
contrast, Treg cell function is largely normal in cells lacking mTORC2 activity (Zeng,
Yang et al. 2013). Park et al. demonstrated that the mTORC1 signaling threshold
maintains Treg cell stability and function. Briefly, the absence of Tsc1 in Treg cells
causes dysregulated immune homeostasis. Tsc1-deficient Treg cells are unstable and
acquire an effector TH17-like phenotype (Park et al., 2013). These studies highlight the
critical role of mTORC1 signaling in Treg cell function. However, the inhibition of both
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mTORC1 and mTORC2 complex is necessary for the generation of iTreg cells (Delgoffe
et al., 2009; Delgoffe et al., 2011), suggesting that mTOR signaling is a complex
regulator of Treg cell biology.
Upstream signals modulate mTOR signaling to control Treg cell function. For
example the sphingosine-1-phosphate receptor 1 (S1PR1)-mTOR axis controls the
programming of Treg cells in the thymus and periphery, thereby limiting the suppressive
function of Treg cells in vivo and in vitro (Liu et al., 2009; Liu et al., 2010). Autocrine
signaling of the hormone leptin modulates Treg cell proliferation via the leptin receptor.
It has been reported that leptin strongly induces mTORC1 activity in Treg cells.
Additionally, transient mTORC1 inhibition and loss of either leptin or its receptor
receptor subsequently promotes anti-CD3/28-induced Treg cell proliferation.
Interestingly, the expression of leptin and leptin receptor by Treg cells is regulated by
mTORC1 activation, because short-term rapamycin treatment suppresses their
expressions. Therefore, the leptin-mTOR pathway dynamically regulates energy
metabolism essential for Treg cells to control self-tolerance (Procaccini et al., 2010).
mTOR and T cell metabolism
Distinct metabolic programs exist throughout different stages of T cell
development. Quiescent naïve T cells engage oxidative phosphorylation (OXPHOS) or
fatty acid oxidation (FAO) to generate adenosine triphosphate (ATP) (Fox et al., 2005;
Pearce and Pearce, 2013; van der Windt and Pearce, 2012; Wang et al., 2011). Activated
T cells require greater energy demands to rapidly grow and proliferate, which is mediated
primarily by aerobic glycolysis (MacIver et al., 2013; Vander Heiden et al., 2009).
Furthermore, TH1, TH2 and TH17 cells rely upon glycolysis, whereas Treg cells engage
fatty acid oxidation (Michalek et al., 2011a; Zeng and Chi, 2013). Extensive crosstalk
between metabolic programming and the mTOR signaling pathway is crucial for T cell
fate decisions (Buck et al., 2015). Briefly, rapamycin treatment in activated T cells blocks
c-Myc expression as well as glycolytic activity (Shi et al., 2011; Wang et al., 2011).
Although naïve T cells experience comparatively low metabolic activity, increased
mTORC1 activity in Tsc1−/− naïve T cells is linked to the upregulation of genes related to
glucose metabolism (Yang et al., 2011). Upon TCR activation, Tsc2−/− T cells are highly
glycolytic (Michalek et al., 2011b). Tone of the downstream targets of mTORC1, HIF1α, plays a crucial role in glycolysis. Interestingly, HIF-1α−/− mice have increased Treg
cells, pointing to an inhibitory role for glycolytic metabolism in Treg cell function (Shi et
al., 2011). Furthermore, a recent study from our lab suggested that dysregulated
glycolytic activity can impair Treg cell stability (Wei et al., 2016). We further explore the
link between glycolytic metabolism and Treg cell function in this project.
Phosphatase and Tensin Homolog (PTEN)
The Pten gene was identified in 1997 as a tumor suppressor and is also known as
Telomerase-Associated Protein 1 (TEP1) and Mutated in Multiple Advanced Cancers 1
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(MMAC1) (Li and Sun, 1997; Li et al., 1997; Steck et al., 1997). This gene is located in
long (q) arm of chromosome 10 at position 23.3 and is frequently mutated in a large
number of human cancers (Chalhoub and Baker, 2009). In humans, germline mutations in
PTEN are associated with several cancers and developmental disorders. PTEN
Hamartoma Tumor Syndrome (PHTS) is a spectrum of disorders caused by loss of
function of PTEN. PHTS includes Cowden syndrome (CS), Bannayan-Riley-Ruvalcaba
syndrome (BRRS), PTEN-related Proteus syndrome (PS), and Proteus-like syndrome
(PLS) (Hobert and Eng, 2009). Additionally, heterozygous loss of PTEN function or
expression is known to cause autoimmune disease and cancers (Salmena et al., 2008;
Song et al., 2012). Even nearly 20 years after its discovery, most PTEN-related research
studies have focused on its tumor suppressor functions. Little is known regarding the role
of PTEN in autoimmune disorders, specifically within Treg cells, which we aim to
characterize in this project.
Structure and regulation of PTEN
PTEN is composed of 403 amino acids and has five distinct functional domains,
which are the N-terminal region PIP2 binding domain, a phosphatase domain for
enzymatic activity, a C2 domain for membrane recruitment, a carboxy-terminal tail
thought to maintain stability and a PDZ-binding domain for protein interactions
(Figure 1-6) (Georgescu, 2010; Leslie et al., 2008; Song et al., 2012). The function of
PTEN is regulated through various mechanisms. Epigenetic changes via DNA promoter
methylation modulate Pten expression at the transcription level. The proteins zinc finger
protein SNAI1 (SNAIL), c-Jun N-terminal protein kinases (JNK), and MYC and
Mitogen-Activated Protein Kinase Kinase Kinase 4 (MEKK4) are well-known
suppressors of Pten transcription, among many others. In contrast, PPARγ and the p53
pathway upregulate Pten transcription. The NOTCH1 pathway, which plays important
roles in T cell development and Treg cell function (Asano et al., 2008; Charbonnier et al.,
2015; Deftos and Bevan, 2000), both positively and negatively regulates Pten
transcription in a context-dependent manner (Salmena et al., 2008; Song et al., 2012).
PTEN expression is also controlled at the post-transcriptional level. First,
endogenous, non-coding RNAs known as microRNAs (miRNAs) are essential regulators
of PTEN expression. For instance, miR-19, miR-21, miR-26a and the miR-17~92 cluster,
and miR-153 suppress PTEN expression (Huse et al., 2009; Meng et al., 2007; Olive et
al., 2009; Song et al., 2012; Wu et al., 2013; Xiao et al., 2008). Additionally, posttranslational phosphorylation events regulate the function of PTEN. The phosphorylation
of several C-terminal residues (S365, T366, T382, S385, and T388) of PTEN is
associated with its localization and stability (Bermúdez Brito et al., 2015; Salmena et al.,
2008). In the context of diseases, the aberrant regulation of PTEN can occur at the
genetic level. Allelic loss and mutations within different exons causes functional
inactivation of PTEN. The loss of single PTEN allele is often seen in sporadic cancers,
whereas homozygous loss is often correlated with advanced cancer and metastasis
(Hollander et al., 2011; Pezzolesi et al., 2007; Song et al., 2012). We discuss the T cellspecific control of PTEN later in this chapter.
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Figure 1-6. PTEN gene structure.
Structure of 403 amino acids long PTEN gene with five different functional domains.
Reprinted with permission. Leslie, N.R., Batty, I.H., Maccario, H., Davidson, L., and
Downes, C.P. (2008). Understanding PTEN regulation: PIP2, polarity and protein
stability. Oncogene 27, 5464-5476.
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Activation of mTOR by PTEN
Many signals, including TCR, co-stimulatory, and cytokines, induce PI3K
signaling in T cells (Chapman and Chi, 2014; Chi, 2012). PI3K phosphorylates the
membrane lipid, PIP2, to generate PIP3. One function of PIP3 is to modulate protein
localization by recruiting proteins with pleckstrin homology domains to the plasma
membrane. PDK1 and AKT are two such proteins activated downstream of PI3K.
Mechanistically, PDK1 phosphorylates AKT T308, and phosphorylation of AKT S473 by
mTORC2 promotes maximum catalytic function of AKT. Active AKT drives cell
survival, proliferation and cellular metabolism, in part by phosphorylation of the Foxo
family proteins. AKT also activates mTORC1, which is a central regulator of cell
metabolism, growth, proliferation and survival as discussed above (Figure 1-4) (Chi,
2012). TCR/CD28-induced mTORC1 is activated via a PI3K-PDK1-dependent, AKTindependent pathway in activated CTLs and Treg cells (Finlay et al., 2012; Wei et al.,
2016). Further, we found upregulation of the PI3K-PDK1 pathway is correlated with
reduced Treg cell stability and function (Wei et al., 2016) Additionally, PI3K signaling is
positively linked to mTORC2 activation, because PIP3 appears to directly activate
mTORC2 kinase activity (Gan et al., 2011; Liu et al., 2015). Because PTEN controls the
regulative balance of PIP3 available for driving PDK1, AKT, mTORC1, and mTORC2
function, PTEN might also be an essential regulator of Treg survival, proliferation,
stability or suppressive function.
Regulation and roles of PTEN in T cells
While PTEN expression is crucial for its function as a tumor suppressor, PI3K
activation depends on downregulation of PTEN. Therefore, T cell responses, including
proliferation and survival, depend on temporal instances of low PTEN expression.
Studies have shown that TCR stimulation is sufficient to inhibit PTEN expression
(Bensinger et al., 2004; Locke et al., 2009; Walsh et al., 2006), thus activating the PI3K
pathway. However, CD28 costimulatory signals require PTEN (Buckler et al., 2006). It is
also known that the expression of Pten is higher in Treg cells than in effector T cells
(Bensinger et al., 2004; Zeiser et al., 2008). These results suggest that PTEN expression
is a critical determinant of T cell functions.
Conditional gene knockout and germline knockout approaches have been used to
study the tumor suppressor function of PTEN. Initially, the role of PTEN in T cells was
analyzed in Pten+/- mice, because complete disruption of Pten results in early embryonic
lethality (Di Cristofano et al., 1998; Suzuki et al., 1998). These Pten+/- mice develop
CD4+ T cell lymphoma and autoimmunity (Di Cristofano et al., 1999). To understand the
intrinsic role of PTEN, Pten was conditionally deleted within the T cell compartment
(Suzuki et al., 2001). Analyses of these mice demonstrated that the regulation of PIP3
levels by PTEN is important for T-cell development and T-cell responses to activation
and apoptotic-inducing signals. The analysis of T-cell conditional knockout mice
revealed the loss of PTEN signaling during T cell lineage programming drives
preferential TH2 differentiation (Buckler et al., 2008). Given the evidence that PTEN has
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a profound impact on many aspects of T cell development and autoimmunity, one might
predict that the Treg cell population would be altered in Pten conditional knockout mice.
However, by using tissue-specific conditional deletion or transgenic mice, several groups
have found that Treg cells appear to develop normally and their suppression ability seems
to be intact in the absence of Pten ( Buckler et al., 2008; Walsh et al., 2006).
Additionally, Pten-deficient Treg cells tend to be hyperpoliferative to IL-2 signaling
alone due to the inability to activate PI3K (Walsh et al., 2006). In summary, studies have
shown loss of PTEN function in T cells disrupts immune tolerance, but there is a need for
further study to elucidate the role of PTEN specifically in Treg cells.
Rationale and Hypothesis
Although previous studies suggest PTEN is an important regulator of T cell
selection and cell fate decisions, (Buckler et al., 2008; Walsh et al., 2006), those studies
provided little direct evidence for a cell-intrinsic role for PTEN in Treg cell function.
Therefore, we generated mice with a Treg-specific deletion of Pten to circumvent the
potential influence of Pten deletion within multiple T cell populations. Using this system,
we also minimize the undesired Cre-mediated toxicity (Schmidt-Supprian and Rajewsky,
2007). The purpose of the study was to investigate the requirement of PTEN in the
homeostasis and functions of Treg cells. We hypothesized that the loss of Pten in Treg
cells would result in defective immune regulation.
Conclusion
Much of the recent emphasis has been placed on the roles of transcription factors
that program Treg lineage stability and functional diversity, but how immunological
signals are sensed and integrated by Treg cells to impinge upon distinct effector
responses remains obscure. The data presented in this dissertation support a role for the
PTEN-mTORC2 axis in regulating Treg cell stability and suppressive functions that
dampen TH1 and TFH responses linked to systemic autoimmunity. Our results presented in
Chapters 3 through 5 have led to a better understanding of how PTEN orchestrates Treg
cell stability and functional diversity.
Additionally, another project presented in Appendix (Figures A-1 to A-13)
discusses how mTORC1 controls the function of memory T cells. The findings establish
the role of the upstream mTORC1 regulator, TSC1 in immune signaling and cell
metabolism necessary to orchestrate memory CD8+ T-cell differentiation and function.
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CHAPTER 2.

METHODS AND MATERIALS*
Mice

Ptenfl/fl, CD45.1+, Rag1−/−, Ifng−/− and Rosa26GFP (harboring a loxP-site-flanked
STOP cassette followed by the GFP-encoding sequence inserted into the Rosa26 locus)
mice were purchased from the Jackson Laboratory. Rictorfl/flFoxp3-Cre mice have been
described (Zeng et al., 2013). Foxp3YFP-Cre mice were a gift from Dr. A. Rudensky
(Rubtsov et al., 2008) and Foxo1AAA/+, from Dr. M.O Li (Ouyang et al., 2012).
Ptenfl/flFoxp3-Cre mice were analyzed at 10–12 weeks of age unless otherwise noted
using age and sex-matched Foxp3-Cre mice as controls (referred to as WT). All mice
were housed in a specific pathogen-free facility in the Animal Resource Center at St.
Jude Children's Research Hospital. Animal protocols were approved by the Institutional
Animal Care and Use Committee of St. Jude Children's Research Hospital.
Bone Marrow Chimera
Bone marrow (BM) chimeras were generated by transferring 7 × 106 T-cell–
depleted bone marrow cells into sublethally irradiated (5 Gy) Rag1−/− mice, followed by
reconstitution for at least 2.5 months. Baytril water was used as an antibiotic treatment
for BM chimeras for three weeks after irradiation.
Polymerase Chain Reaction
Polymerase chain reaction was used to genotype mice using primers (Invitrogen)
listed in Table 2-1. A master mix of nuclease-free water, 1X Tsg enzyme buffer, 25 mM
MgCL2, 10 mM dNTPs (all from Lamda Biotech), allele-specific primers and Tsg enzyme
was prepared. Genomic DNA purified from mouse toe, tail, or ear clips was then added to
each PCR reaction. Each set of PCR reactions also contained a positive and a negative
control. Programs used to run the reaction in the thermal cycler are listed in Table 2-2.
The samples were mixed with 6X DNA loading dye (Lamda Biotech) and loaded onto
1% agarose gel. Bands were visualized with GelRed (Biotium) on a Gel Doc 2000
(Biorad). The samples were scored according the band size listed in Table 2-1.
Single Cell Suspension
Mice were sacrificed by CO2 asphyxiation and organs (spleen, mesenteric lymph
and peripheral lymph nodes that included inguinal, auxiliary and cervical lymph nodes)
-----------------------*Chapter 2 adapted with permission. Shrestha, S., Yang, K., Guy, C., Vogel, P., Neale,
G., and Chi, H. (2015). Treg cells require the phosphatase PTEN to restrain TH1 and TFH
cell responses. Nature immunology 16, 178-187.

23

Table 2-1.
Primer
Name
Foxp3YFP
-Cre

Pten

List of PCR primers used for PCR.
Forward Primer

Reverse Primer

AGGATGTGAGGGA

TCCTTCACTCTGAT

Product
Length (bp)
346

CTACCTCCTGTA

TCTGGCAATTT

(knockin)

GCGTATGATCAGT

CTGCCCTCCTAGA

423 (wild-

TATGCCTGTGTGG

TCATATCATCTGCC

type)

CAAGCACTCTGCG

AAGTTTTTGAAGG

328 (loxP)

AACTGAG

CAAGATGC

156 (wildtype)

IFN-γ

Rictor

AGAAGTAAGTGGA

AGGGAAACTGGGA

320

AGGGCCCAGAAG

GAGGAGAAATAT

(mutant)

TCAGCGCAGGGGC

ATCGACAAGACCG

260 (wild-

GCCCGGTTCTTT

GCTTCCATCCG

type)

ACTGAATATGTTC

GAAGTTATTCAGA

554 (loxP)

ATGGTTGTG

TGGCCCAGC

466 (wildtype)
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Table 2-2.

PCR program used to amplify gene of interest.
PTEN and IFN-γ
o
94 C for 2:00 min

Foxp3YFP-Cre and Rictor
94oC for 2:00 min

94oC for 0:45 min

94oC for 0:30 min

65oC for 0:45 min

60oC for 0:30 min

- 0.3oC per cycle

72oC for 1:00 min

72oC for 1:00 min

Goto 2, repeat 39 times

Goto 2, repeat 41 times

72oC for 5:00 min

72oC for 5:00 min

15oC for 5:00 min

15oC for 5:00 min

End

End
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were harvested. The procedures here onwards were done in sterile conditions under the
hood. Organs were placed in 10-cm petri dishes containing 1 mL of wash buffer (HBSS +
2% FBS). 70-μm nylon mesh was laid over the organs, and the flat end of a 3 mL syringe
was used to gently grind the organs to create single cell suspensions. The mesh was
washed with wash buffer, and the cells were collected in a 15-mL conical tube. Cells
isolated from the lymph nodes were used immediately for downstream assays.
Splenocytes were centrifuged and then resuspended in 1 mL of ACK lysis buffer (Gibco).
After 1-2 minutes, the cells were washed, centrifuged and resuspended in appropriate
volume of wash buffer.
Cell Purification
Single cell suspensions from pooled spleen and peripheral lymph nodes were
stained with magnetic L3T4 CD4+ T cell isolation microbeads (Miltenyi Biotech) for 15
minutes at 4oC. The cells were subsequently washed and resuspended in wash buffer and
filtered through a MACS MS column (Miltenyi Biotech) for positive selection of CD4+ T
cells. The enriched cells were washed and stained with the appropriate surface markers
for 30 minutes in 4oC. Cells were then washed, and naïve and Treg cells were sorted
using a MoFlow (Beckman-Coulter) or Reflection (i-Cyt) fluorescence-based cell sorter
based on the surface markers listed in Table 2-3.
Flow Cytometry
For analysis of surface markers, cells were stained in FACS buffer (PBS
containing 2% (wt/vol) bovine serum albumin (BSA)). The following antibodies were
used for flow cytometry analysis: anti-CD4 (RM4-5), anti-CD8α (53-6.7), anti-TCRβ
(H57-597), anti-CD69 (H1.2F3), anti-CD25 (PC61.5), anti-CD44 (1M7), anti-CD62L
(MEL-14), anti-CD45.1 (A20), anti-CD45.2 (104), anti-PD-1 (J43), anti-GL7 (GL-7),
anti-CD95 (15A7), anti-ICOS (C398.4A), anti-GITR (DTA-1), anti-CD19 (1D3), antiCXCR3 (CXCR3-173), anti-MHCII (M5/114.15.2), anti-CD11b (M1/70), anti-CD11c
(N418), anti-Ly6G (RB6-8C5; all from eBioscience). CXCR5 was stained with
biotinylated anti-CXCR5 (clone 2G8) followed by streptavidin-conjugated PE (both from
BD Biosciences). Flow cytometry data were acquired on the LSRII or LSR Fortessa flow
cytometer (BD Biosciences) and analyzed using Flowjo software (Tree Star).
Intracellular Staining
For intracellular marker staining, single cell suspensions were resuspended in
FACS buffer containing antibodies for surface markers and incubated for 30 minutes in
4oC. The stained cells were then washed with ice-cold FACS buffer and fixed using
fixation/permeabilization buffer (ebioscience, catalog # 005123-43). One hour later, cells
were washed with 1X permeabilization buffer (ebioscience, catalog # 008333-56) twice
and then stained with intracellular markers for 20 minutes at 4oC. Anti-Foxp3 (FJK-16s),
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Table 2-3.
Characterization of innate and adaptive immune cell surface and
intracellular markers.
Cell Population
Naïve T cells
Activated T cells
Treg cells

Cell Markers
CD62L+ CD44CD44+ CD62LCD4+ TCRβ+ YFP+ or
CD4+ TCRβ+ Foxp3+
CD4+ CXCR5+ PD-1+ or
CD4+ CXCR5+ ICOS+ or
CD4+ CXCR5+ Bcl6+
CD4- CD19+ GL7+ CD95+
CD4+ CXCR5+ PD-1+
YFP+
CD4+ TCRβ+ IFN-γ
CD4+ TCRβ+ IL-17+
CD4+ TCRβ+ IL-4+
CD4- CD19+
MHCII+ CD11c+
Ly6G+ CD11b+

TFH
GC B cells
TFH
TH1
TH17
TH2
B cells
DC
Neutrophils
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anti-T-bet (4B10), anti-IRF4 (3E4), anti-IFN-γ (XMG1.2), anti-IL-4 (11B11), and antiIL-17 (17B7) antibodies were all from eBioscience. Anti-CTLA4/CD152 (UC10-4B9)
and anti-Blimp1 (3H2-E8) were purchased from Biolegend and Thermo Scientific,
respectively. Cells were then washed and analyzed by flow cytometry.
For intracellular cytokine staining, T cells were stimulated for 4 h with 50ng/ml
PMA plus 1 μg/ml ionomycin in the presence of 1X monensin (GolgiSTOP, BD
Bioscience) in 48-well plates at 37oC + 5% CO2. Cells were harvested, stained, and
processed for flow cytometric analysis as above.
For phospho antibody staining, cells were incubated in pre-warmed 1X Phosflow
lyse/fix buffer (BD Biosciences) at 37oC for 10 minutes. Cells were then pelleted by
centrifugation and washed once with FACS buffer. After washing, the cells were
permeabilized by adding 1 mL of ice-cold Phosflow Perm Buffer III (BD Biosciences),
and incubated in ice for 30 minutes. The cells were washed twice with FACS buffer,
stained with antibodies specific for as p-STAT3 (4/P-STAT3), PTEN (A2B1), and Bcl6
(K112-91; all from BD Biosciences) for 1 h at room temperature, and processed for flow
cytometric analysis.
Cell Proliferation Assay
Mice were injected intraperitoneally (i.p) with 1mg of 5-Bromo-2’-deoxyuridine
(BrdU) stock 16 hours before analysis. Single cell suspensions were prepared from
spleen, peripheral and mesenteric lymph nodes and thymus. Cells were stained with
antibodies specific for cell-surface markers for 30 minutes at 4oC, washed and
resuspended in Cytofix/Cytoperm buffer for 15 minutes on ice. Cells were then washed
with Perm/Wash buffer, incubated in Cytoperm Plus buffer for 10 min on ice, washed
again with Perm/Wash buffer and resuspended in Cytofix/Cytoperm buffer. After 5 min
incubation on ice, cells were washed with Perm/Wash buffer, resuspended in PBS
containing 300 ug/ml of DNase I and incubated for 1 h at 37˚C. After washing with
Perm/Wash buffer, cells were stained with anti-BrdU (BD Pharmingen) and processed for
flow cytometric analysis. All buffers and additional reagents described in this protocol
were obtained from BD Biosciences (552598).
Active Caspase-3 Staining
Cells obtained from single cell suspension were first stained with cell surface
makers for 30 minutes at 4oC deg, washed and then fixed using BD Cytofix/Cytoperm
buffer on ice for 20 minutes. Cells were washed twice using BD Perm/Wash buffer and
stained with active Caspase-3 at room temperature for 30 minutes and then processed for
flow cytomeric analysis. All buffers and additional reagents described in this protocol
were in the active caspase-3 apoptosis kit (550941) purchased from BD Pharmingen.
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Active Mitochondria Staining
For staining mitochondria, lymphocytes were incubated for 30 min at 37 °C with
10 nM MitoTracker Deep Red (Life Technologies) or 20 nM TMRM (tetramethyl
rhodamine, methyl ester; ImmunoChemistry Technologies) after staining surface
markers. ROS were measured by incubation with 5 μM MitoSOX Red (Life
Technologies) after staining surface markers. The samples were then analyzed by flow
cytometry.
Immunofluorescence
For cryosections, kidneys and MLNs were freshly frozen in OCT embedding
medium (Ploysciences, Inc). 10-μm-thick cryosections were fixed with cold acetone for 5
min before rehydration in Tris-buffered saline (TBS). Nonspecific binding was blocked
by incubation in TBS containing 2% BSA and 5% normal donkey serum for 30 min
before incubation with primary antibodies (2 μg/ml) overnight at 4 °C. Slides were
washed for 15 min in TBS before incubation with Alexfluor568-conjugated goat antimouse antibody (1 μg/ml; A11031; Life Technologies), Alexfluor568-conjugated donkey
anti-goat antibody (1 μg/ml; A11057; Life Technologies), Cy5-conjugated donkey antigoat antibody (1 μg/ml; 705-175-147; Jackson ImmunoResearch), or Alexfluor488conjugated streptavidin (1 μg/ml; S11223; Life Technologies) for 1 h at room
temperature. Slides were washed for 15 min in TBS before mounting in Vectashield hard
set with DAPI (Vector Laboratories). Fluorescence images were acquired using a Zeiss
Axiovert200M and 20X EC Plan-NeoFluar objective, detected using a Cascade II
EMCCD camera (Photometrics) and analyzed using Slidebook software (3i Intelligent
Imaging Innovations). Large image composites were acquired with a Nikon Ti-E inverted
microscope with 20× CFI Plan Apochromat Lambda objective and iXon DU897 EMCCD
camera, using NIS-Elements software.
Visualization of ANA antibodies was performed by staining fixed Hep-2 slides
(MBL). Specifically, serum samples were applied to the slide and incubated for 2 h at
room temperature followed by 15 min washing in TBS. Bound murine antibodies were
detected using Alexfluor568-conjugated goat anti-mouse antibody (1 μg/ml; A11031;
Life Technologies) for 1 h at room temperature, and Alexafluor488-conjugated phalloidin
(A12379; Life Technologies) was used to visualize F-actin, and nuclei were detected
using DAPI. The anti-CD3 (sc-1127 (M-20)) antibody was purchased from Santa Cruz,
Biotinylated Peanut Agglutinin (PNA) from Vector Laboratories (B-1075), and IgD
(558597) from BD Biosciences.
Immunohistochemistry
For paraffin sections, the spleen, kidney and Peyer's patches were fixed by
immersion in 10% (vol/vol) neutral buffered formalin solution. Fixed tissues were
embedded in paraffin, sectioned and stained with hematoxylin and eosin, and the clinical
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signs of autoimmune diseases were analyzed by an experienced pathologist (Dr. Peter
Vogel), blinded to sample identity.
Immunization
For experiments involving antigen-induced TFH and GC B cell response, antigen
for immunization was prepared by mixing NP14-OVA (14 molecules of NP linked to
OVA; Biosearch Technologies) and 10% KAl(SO4)2 dissolved in PBS at a ratio of 1:1, in
the presence of LPS (Escherichia coli strain 055:B5; Sigma). The solution was set to pH
7, and NP-OVA (100 μg) and LPS (10 μg) precipitated in alum was injected
intraperitoneally as described (Kang et al., 2013).
Alternatively, a fresh preparation of 1 × 109 PBS-washed 1 × 109 SRBCs from
Colorado Serum Company (31112) were injected intravenously to induce a robust splenic
GC response (Cato et al., 2011).
Serum Antibodies
100μl of blood from WT and Ptenfl/flFoxp3-Cre mice was collected in 1.5ml tubes
and placed at room temperature for 30 minutes. The tube containing the blood was then
centrifuged in 1000g for 10 minutes. The supernatant was then used for autoantibodies
(dsDNA) and immunoglobulin subclasses detection assays with kits from Alpha
Diagnostic International (5110) and Millipore (MGAMMAG-300K), respectively.
Adoptive Transfer
For adoptive transfer, sorted CD4+CD25+Foxp3-YFP+cells from Foxp3-Cre
and Ptenfl/flFoxp3-Cre mice (CD45.2+) were transferred to the congenically marked
(CD45.1+) recipients. Seven days after the transfer, mice were euthanized for the analysis
of Foxp3 and CD25 expression.
Cell Counting
The automated Nexcelom Bioscience Cellometer Auto T4 was used to count cell
numbers. Alternatively, the cell suspension was mixed with trypan blue and counted
using hemocytometer chamber.
Cells per ml = the average count per square x the dilution factor x 104
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Quantitative RT-PCR
RNA was extracted from cells using the RNeasy micro kit (Qiagen), and cDNA
was synthesized with SuperScript III reverse transcriptase (Invitrogen). An ABI 7900
Real-time PCR system was used for quantitative PCR, with primer and probe sets from
Applied Biosystems. The probes were (Pten, Mm00477208_m1), Ifng (forward TCGAATCGCACCTGATCACTA; reverse – GGGTTGTTCACCTCGAACTTG and
probe – CATCCTTTTTTGCTTTACTGTTGCTGAAGAAG).
Results were analyzed with SDS 2.1 software and in Graphpad prism. The cycling
threshold value of the endogenous control gene (β-actin) was subtracted from the cycling
threshold value of each target gene to generate the change in cycling threshold (DeltaCT).
The expression of each target gene is presented as the fold change relative to that of wildtype unstimulated samples using the delta delta CT method (Menon et al., 2007).
Immunoblotting
For immunoblotting, the immunoprecipitates or whole-cell lysates were resolved
on SDS-PAGE gels and transferred to polyvinylidene difluoride membranes (Bio-Rad)
and blocked using 5% non-fat milk (Bio-rad) in TBST (1X TBS from Bio-rad containing
0.1% Tween-20). The membranes were incubated with various antibodies diluted in 5%
Bio-Rad blocking buffer and washed using 0.1% TBST. The bound antibodies were
visualized with Horseradish peroxidase (HRP) conjugated antibodies against mouse or
rabbit IgG by using SuperSignal West Dura Extended Duration Substrate (Thermo Fisher
Scientific). The images were obtained using film.
Primary antibodies used were the following: anti-p-S6 (Ser235/236) (2F9, Cell
Signaling Technology), anti-p-4E-BP1 (Thr37/46) (236B4, Cell Signaling Technology),
anti-p-Foxo1 (Ser256) (9461, Cell Signaling Technology), anti-p-AKT S473 (D9E, Cell
Signaling), anti-PTEN (138D6; Cell Signaling Technology) and anti-β-actin (AC-15;
Sigma). The primary antibody dilutions were 1:1,000 (phospho-antibodies and PTEN
antibody) and 1: 2,000 (β-actin antibody).
Glycolysis Assay
Treg cells were stimulated with plate-bound anti-CD3-CD28 for 6 h, and
glycolytic flux was measured by detritiation of [3-3H]-glucose, as described (Shi et al.,
2011).
Gene-expression Profiling and Gene-set Enrichment Analysis
DNase-treated RNA samples from sort-purified WT or PTEN-deficient Treg cells
were analyzed with the Affymetrix HT MG-430 p.m. GeneTitan peg array, and
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expression signals were summarized with the robust multi-array average algorithm
(Affymetrix Expression Console v1.1). Lists of genes differentially expressed by 1.5-fold
or more were analyzed for functional enrichment using the Ingenuity Pathways
(http://www.ingenuity.com). GSEA within canonical pathways was performed as
described (Subramanian et al., 2005). The microarray data have been deposited into the
GEO series database (GSE63625).
Statistical Analysis
P values were calculated with Student's t-test (GraphPad Prism). P < 0.05 was
considered significant. All error bars represent mean and s.e.m.
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CHAPTER 3. CHARACTERIZATION OF IMMUNOLOGICAL EFFECTS
MEDIATED BY PTEN SIGNALING IN TREG CELLS*
Introduction
We and others have shown a central role for mTOR in T cell-mediated immune
responses (Chi, 2012; Powell et al., 2012). As mTOR is activated by diverse upstream
signals and serves multifactorial roles in T cell responses, multiple mechanisms actively
enhance or suppress mTOR signaling (Chi, 2012). For instance, loss of the tumor
suppressor TSC1 aberrantly upregulates mTORC1 activity and disrupts T cell
quiescence, homeostasis and functions (Yang et al., 2011). As a pluripotent molecule,
PTEN antagonizes PI3K activity and thus has been shown to inhibit both mTORC1 and
mTORC2 complexes (Chi, 2012); Deletion of Pten in T cells leads to the development of
leukemia and autoimmunity (Liu et al., 2010; Suzuki et al., 2001). PTEN also possesses
nuclear functions independent of PI3K-AKT activity (Song et al., 2011). Although PTEN
has been implicated in the homeostasis and abundance of Treg cells (Bensinger et al.,
2004; Zanin-Zhorov et al., 2012), previous studies have demonstrated Pten-deficient Treg
cells maintain their suppressive activity in vitro (Walsh et al., 2006). Therefore, the
functional impacts and molecular pathways of PTEN in Treg cell-mediated immune
homeostasis and function remain to be established.
To investigate the in vivo functions and mechanisms of PTEN in Treg cells, we
developed a mouse model to delete Pten selectively in Treg cells. Treg-specific loss of
Pten was sufficient to induce a systemic, lupus-like autoimmune and lymphoproliferative
disease. This disorder was associated with excessive TFH and GC B cell responses, as
well as exuberant IFN-J production and TH1 reactions. Importantly, deletion of IFN-J
considerably rectified TFH and autoimmune responses, indicating that PTEN signaling in
Treg cells coordinately regulates TH1 and TFH responses.
Treg Cell-specific Deletion of PTEN Precipitates an Inflammatory Disease
Generation of Pten-deficient Treg cell mice
To better understand the role of PTEN in the homeostasis and functions of
Treg cells in vivo, we crossed mice carrying loxP-flanked Pten alleles (Ptenfl/fl)
with Foxp3YFP-Cre (Foxp3-Cre) mice (Rubtsov et al., 2008) to generate mice in which
the Pten conditional alleles are deleted specifically in Treg cells (referred to as
-----------------------*Chapter 3 reprinted with permission. Shrestha, S., Yang, K., Guy, C., Vogel, P., Neale,
G., and Chi, H. (2015). Treg cells require the phosphatase PTEN to restrain TH1 and TFH
cell responses. Nature immunology 16, 178-187.
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Ptenfl/flFoxp3-Cre mice). PTEN was deleted efficiently at both at the mRNA and protein
levels in Treg cells but not in other T cell subsets (Figure 3-1).
Phenotypic characterization of Ptenfl/flFoxp3-Cre mice
Ptenfl/flFoxp3-Cre mice were phenotypically indistinguishable from littermate
controls (Foxp3-Cre mice, designated as WT) from birth to 2-3 months of age. However
4-5-months-old Ptenfl/flFoxp3-Cre mice spontaneously developed cervical lymph node
hyperplasia at. At this age, the Ptenfl/flFoxp3-Cre mice also displayed modest
splenomegaly (Figure 3-2A).
Next, we wanted to assess if there was a global inflammatory response in
Ptenfl/flFoxp3-Cre mice. Routine histological examination by H&E staining was
conducted in groups of mice at different age intervals. Most of the organs in
Ptenfl/flFoxp3-Cre mice had multifocal inflammation (unpublished observations).
Interestingly, the number and size of reactive follicles in Peyer’s patches were greater in
Ptenfl/flFoxp3-Cre mice than WT mice (Figure 3-2B). This finding of Peyer’s patch
abnormality and the spontaneous development of lymphoadenopathy in Ptenfl/flFoxp3Cre mice indicated an ongoing lymphoproliferative disease, although it was not lethal and
no signs of malignancies were identified. The affected mice were able to survive more
than a year (unpublished observations).
Disruption of immune system in Ptenfl/flFoxp3-Cre mice
To clarify if the pathology of Ptenfl/flFoxp3-Cre mice was related to the
development of a systemic autoimmune disease rather than lymphoma, we quantified
total antibody and autoantibody activity in the serum of WT or Ptenfl/flFoxp3-Cre mice.
The amounts of anti-dsDNA and anti-nuclear antigen (ANA) autoantibodies in the serum
were measured using ELISA and binding to fixed Hep-2 slides, respectively. We found
significantly increased titers of circulating anti-dsDNA and ANA antibodies in
Ptenfl/flFoxp3-Cre mice compared with WT (Figure 3-3A and B), indicative of
autoimmune reactions. Furthermore, upon examination of mouse immunoglobulin
isotypes, we found considerably elevated titers of serum IgG2a/c and IgG2b isotypes in
Ptenfl/flFoxp3-Cre mice. In contrast, IgG1 and IgG3 titers were reduced, while IgM and
IgA titers were comparable between WT and Ptenfl/flFoxp3-Cre mice (Figure 3-4).
Lymphocytic infiltration leading to predominant renal nephritis is frequently
associated with clinical manifestations of systemic or non-organ specific autoimmune
diseases. We therefore examined the glomerular architecture of the kidney in
Ptenfl/flFoxp3-Cre mice. To our expectation, the size and cellularity of the glomeruli were
greatly increased in the kidney from Ptenfl/flFoxp3-Cre mice, indicative of
glomerulonephritis (Figure 3-5). Furthermore, immunofluorescence imaging revealed
prominent IgG deposits in the kidney glomeruli of Ptenfl/flFoxp3-Cre mice (Figure 3-6).
In summary, these results highlight that loss of Pten in Treg cells results in the
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Figure 3-1. Analysis of Pten mRNA and PTEN protein expression in Treg cells.
Real-time PCR analysis of Pten mRNA expression in Treg and naïve CD4+ T cells (left)
and histogram from flow cytometry analysis showing PTEN protein expression in
CD4+YFP+, CD4+YFP– and CD8+ T cells from the spleen of WT and Ptenfl/flFoxp3-Cre
mice (right). Results were normalized using β-actin housekeeping gene and expressed as
fold change for real-time PCR.
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Figure 3-2. Age-related lymphoproliferative disease seen in Ptenfl/flFoxp3-Cre
mice.
(A) Images of spleen and peripheral lymph nodes from WT (upper, ~5 months old),
Ptenfl/flFoxp3-Cre mice prior to the development of lymphoproliferative disease (middle,
~2.5 months old), and Ptenfl/flFoxp3-Cre with lymphoproliferative disease (lower, ~5
months old). (B) Hematoxylin and eosin (H&E) staining of Peyer’s patches in the
intestine of WT and Ptenfl/flFoxp3-Cre mice (magnification: left, x4; and right, x20).
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Figure 3-3. Ptenfl/flFoxp3-Cre mice develop spontaneous systemic autoimmune disease.
(A) Quantification of dsDNA-specific IgG in the serum of WT and Ptenfl/flFoxp3-Cre (2-6 months old; WT, n = 19; Ptenfl/flFoxp3-Cre,
n = 24). (B) Immunofluorescence image (scale 20 μm) and quantification of fluorescent intensity (right) of serum ANA IgG
autoantibodies detected with fixed Hep-2 slides. Data are mean ± s.e.m. *P < 0.05 and **P < 0.001.
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Figure 3-4. Dysregulation of immunoglobulins isotype in Ptenfl/flFoxp3-Cre mice.
Quantification of IgG subclasses, IgM and IgA in the serum of WT and Ptenfl/flFoxp3-Cre mice (the IgG2a binding antibody shows
cross-reactivity with IgG2c). Data are mean ± s.e.m. NS, not significant; *P < 0.05, **P < 0.01 and ***P < 0.001.
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Figure 3-5. Structural integrity of the kidney in WT and Ptenfl/flFoxp3-Cre mice.
Representative images of kidney glomerulus sections stained with H&E stain (magnification: x60, scale bar 50 μm). The size and
cellularity of the glomeruli of Ptenfl/flFoxp3-Cre mice (right) were greatly increased in the kidney, indicative of glomerulonephritis.
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Figure 3-6. Imaging analysis of kidney glomeruli of Ptenfl/flFoxp3-Cre mice.
Immunofluorescence images (left) and quantification (right) of kidney glomerulus sections showing IgG deposits (scale 20 μm) in WT
and Ptenfl/flFoxp3-Cre mice. Data are mean ± s.e.m. **P < 0.001.
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development of a systemic autoimmune disorder characterized by aberrant antibody
responses.
Altered Immune Homeostasis upon Treg-specific Loss of PTEN
Disturbances in homeostasis cause T cells to upregulate effector functions, and
this processes can contribute to autoimmune manifestations (Theofilopoulos et al., 2001).
The development of the autoimmune and lymphoproliferative disease prompted us to
examine whether homeostasis of the immune system was altered in Ptenfl/flFoxp3-Cre
mice. In our following analyses, we used mice at a young age, prior to the development
of the lymphoproliferative disease.
PTEN is essential for Treg cell-mediated immune homeostasis
In the steady-state environment, WT and Ptenfl/flFoxp3-Cre mice had comparable
numbers of CD4+or CD8+ T cells, B cells, dendritic cells, and neutrophils (Figure 3-7).
However, the numbers of activated CD62LloCD44hi effector/memory T cells in the CD4+
and CD8+ compartments were increased in Ptenfl/flFoxp3-Cre mice (Figure 3-8).
Moreover, CD44hi cells from these mice expressed elevated levels of IFN-J
(Figure 3-9A). Similarly, expression of CXCR3, the signature chemokine receptor of
TH1 cells, was also elevated (Figure 3-9D). In contrast, IL-17 and IL-4 production was
largely normal (Figure 3-9B and C). Thus, T cells from Ptenfl/flFoxp3-Cre mice were
spontaneously activated in vivo, with a propensity to differentiate into the TH1 phenotype.
Despite severe autoimmune diseases, Ptenfl/flFoxp3-Cre mice had increased percentage
and numbers of Foxp3+ Treg cells in the spleen and lymph nodes (Figure 3-10A).
Cell death and proliferation in Pten-deficient Treg cells
To explore the underlying basis for the increased Treg cellularity, we used
caspase-3 staining and BrdU incorporation assays to measure Treg cells apoptosis and
proliferation, respectively. Treg cells from WT and Ptenfl/flFoxp3-Cre mice had
comparable caspase-3 staining (Figure 3-10B), but Ptenfl/flFoxp3-Cre Treg cells had
more BrdU incorporation than WT cells (Figure 3-10C), indicative of an elevated rate of
proliferation. Therefore, Pten deficiency causes an increased Treg cellularity and
proliferation.
Uncontrolled TFH Responses and GC B Cells in Pten-deficient Treg Mice
Systemic lupus erythematosus (SLE), the prototypical systemic autoimmune
disease, is characterized by the heterogeneity of the underlying T cell responses. Aside
from the roles of the conventional effector (e.g. TH1 and TH17) and regulatory responses,
recent studies demonstrate a crucial role of TFH cells in the overproduction of pathogenic
autoantibodies and tissue damage in SLE (Crotty, 2011; Linterman et al., 2009).
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Figure 3-7. Flow cytometric analysis of different immune cell populations.
(A) Analysis and quantification of CD4+ and CD8+ T cells (B) B cells, (C) conventional
dendritic cells (MCHII+CD11c+) and neutrophils (Ly6G+CD11b+) in the spleen of WT
and Ptenfl/flFoxp3-Cre mice. Numbers indicate percentage of cells in quadrants or gates.
Data are mean ± s.e.m. NS, not significant.
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Figure 3-8. Altered T cell homeostasis in Ptenfl/flFoxp3-Cre mice.
Expression of CD62L and CD44 on WT and Ptenfl/flFoxp3-Cre splenic T cells. Numbers
indicate percentage of cells in quadrants or gates. Ptenfl/flFoxp3-Cre mice have a higher
frequency of activated CD44hiCD62Llo and a lower frequency of naïve CD44loCD62Lhi T
cells. Numbers indicate percentage of cells in quadrants or gates.
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Figure 3-9. TH1 immune responses are increased in Ptenfl/flFoxp3-Cre mice.
Expression of (A) IFN-γ, (B) IL-4 and (C) IL-17 in CD4+ and CD8+ T cells of WT and Ptenfl/flFoxp3-Cre mice after in vitro
stimulation for 4 h with phorbol 12-myristate 13-acetate (PMA) plus ionomycin in the presence of monensin. Numbers indicate
percentage of cells in quadrants or gates. (D) Expression of CXCR3 on CD4+ T cells from the spleen of WT and Ptenfl/flFoxp3-Cre
mice. Numbers in the graph indicate mean fluorescence intensity of CXCR3.
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Figure 3-10. Ptenfl/flFoxp3-Cre mice have an increased frequency of Treg cells.
(A) Flow cytometric analysis of Treg cells in WT and Ptenfl/flFoxp3-Cre splenic CD4+ T
cells. (B) Caspase-3 activity and (C) BrdU incorporation in Treg cells from the spleen or
peripheral lymph nodes (PLN) at 16 h after BrdU injection in WT and Ptenfl/flFoxp3-Cre
mice. Numbers indicate percentage of cells in quadrants or gates.

45

The development of SLE-like symptoms in Ptenfl/flFoxp3-Cre mice prompted us
to examine whether the TFH response was altered in these mice. Under steady state, only a
small percentage of WT splenic CD4+ T cells were stained positive for the TFH signature
molecules, CXCR5 and PD-1, but the CD4+CXCR5+PD-1+ population was greatly
expanded in the spleen and MLNs of Ptenfl/flFoxp3-Cre mice (Figures 3-11A and
3-12A). Similar changes were noticed for CXCR5+ cells expressing the TFH-associated
co-stimulatory molecule ICOS and the transcription factor Bcl6 (Figure 3-12B and C).
The CD4+CXCR5+PD-1+ cells can be further divided into immunostimulatory TFH and
immunoregulatory TFR cells, as indicated by the absence or presence of Foxp3
expression, respectively (Chung et al., 2011; Linterman et al., 2011). Both subsets were
increased in Ptenfl/flFoxp3-Cre mice (Figure 3-11B). Consistent with the increase of
CXCR5+PD-1+ cells, the spleen and MLNs of Ptenfl/flFoxp3-Cre mice contained 3-fold
more GC B cells, denoted by the expression of GC signature markers GL7 and CD95
(Figures 3-11C and 3-12D), even though total B cell numbers were largely unaltered
(Figure 3-7B). Moreover, immunohistochemistry showed that the spleen and MLNs of
Ptenfl/flFoxp3-Cre mice contained considerably more and larger peanut agglutinin (PNA)positive GCs than did their WT counterparts (Figure 3-13A and B). These results
revealed spontaneous TFH and GC formation in Ptenfl/flFoxp3-Cre mice.
We next determined whether Pten deficiency in Treg cells affects TFH and GC
responses after TFH-inducing immunization. After immunization with sheep red blood
cells (SRBCs), a strong protein antigen, the formation of TFH cells and GC B cells was
greatly enhanced in Ptenfl/flFoxp3-Cre mice compared with WT mice (Figure 3-14A).
We observed a similar finding after challenging WT and Ptenfl/flFoxp3-Cre mice with a T
cell-dependent antigen, NP-OVA precipitated in alum and LPS (Figure 3-14B). We
conclude that deletion of Pten in Treg cells results in enhanced TFH and GC reactions
both under steady state and upon immunization.
Coordination of TH1 and TFH Responses by PTEN Signaling in Treg Cells
We next investigated whether the increased TFH response in Ptenfl/flFoxp3-Cre
mice was a cell-autonomous defect. To this end, we generated mixed bone marrow (BM)
chimeras by reconstituting alymphoid Rag1–/– mice with a 1:1 mixture of Ptenfl/flFoxp3Cre CD45.2+ (donor) and CD45.1+ (spike) BM cells (denoted as Ptenfl/flFoxp3Cre:CD45.1+), and as a control, a mixture of WT and CD45.1 cells (denoted as
WT:CD45.1+). The frequency of TFH cells was considerably increased in both the donor
and spike-derived populations in the Ptenfl/flFoxp3-Cre:CD45.1+ chimeras, as compared
with the frequency of TFH cells in the WT:CD45.1+ chimeras (Figure 3-15A).
Additionally, Ptenfl/flFoxp3-Cre:CD45.1+ chimeras had augmented GC B cells
(Figure 3-15B). Thus, Pten deficiency in Treg cells results in a dominantly acting effect
on the TFH and GC responses.
The TH1 cytokines such as IFN-J have been implicated in potentiating TFH
responses (Lee et al., 2012a), although opposing evidence also exists (Nakayamada et al.,
2011; Ray et al., 2014), suggesting a context-dependent effect. We therefore explored
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Figure 3-11. Aberrant TFH, TFR and GC B cells responses in Ptenfl/flFoxp3-Cre
mice.
(A) Left, flow cytometry analysis of TFH cells (CXCR5+PD-1+) cells (gated on
CD4+TCRβ+ cells) in the spleen of WT and Ptenfl/flFoxp3-Cre mice. Right, the frequency
and numbers of TFH cells. (B) Left, analysis of conventional TFH (CD4+CXCR5+PD1+Foxp3-YFP–) and TFR cells (CD4+CXCR5+PD-1+Foxp3-YFP+) in the spleen of WT and
Ptenfl/flFoxp3-Cre mice. (C) Left, analysis of GL7+CD95+ GC B cells (gated on CD19+ B
cells) in the spleen of WT and Ptenfl/flFoxp3-Cre mice. Right, the frequency and numbers
of GC B cells. Numbers indicate percentage of cells in quadrants or gates. Data are mean
± s.e.m. *P < 0.05 and **P < 0.01.
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Figure 3-12. Analysis of TFH and GC B cells.
(A) Flow cytometry of CXCR5 and PD-1 expression (gated on CD4+TCRβ+ cells) in the
MLNs of WT and Ptenfl/flFoxp3-Cre mice. Flow cytometry of (B) CXCR5 and ICOS and,
(C) CXCR5 and Bcl6 expression (gated on CD4+TCRβ+ cells) in the spleen and MLNs of
WT and Ptenfl/flFoxp3-Cre mice. (D) Flow cytometry of GL7 and CD95 expression
(gated on CD19+ cells) in the MLNs of WT and Ptenfl/flFoxp3-Cre mice.

48

Figure 3-13. Immunochistochemistry of germinal centers in WT and Ptenfl/flFoxp3Cre mice.
(A) Germinal center (brown) defined by peanut agglutinin (PNA) staining of spleen
sections of WT and Ptenfl/flFoxp3-Cre mice (magnification, x4; scale bars, 1mm). (B)
Immunofluorescence of germinal center in MLN sections of WT and Ptenfl/flFoxp3-Cre
mice defined by the staining of CD3 (red, marking T cell zones) and PNA (green) (scale
60 μm).
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Figure 3-14. Induction of germinal center responses in WT and Ptenfl/flFoxp3-Cre
mice.
Analysis and quantification of TFH and GC B cells in the spleen of WT and Ptenfl/flFoxp3Cre mice immunized with (A) SRBCs and (B) NP-OVA 7 days previously. Numbers
indicate percentage of cells in quadrants or gates. Data are mean ± s.e.m. *P < 0.05 and
**P < 0.01.
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Figure 3-15. Analysis of bone marrow-derived chimeras reveals dysregulated TFH
and GC B cell responses and IFN-γ overproduction in Ptenfl/flFoxp3-Cre mice.
Sublethally irradiated Rag1–/– mice were reconstituted with a 1:1 mix of CD45.1+ bone
marrow (BM) cells with either CD45.2+ WT or Ptenfl/flFoxp3-Cre BM cells. Following
reconstitution, the mixed chimeras were analyzed for (A) TFH, (B) GC B cells and
intracellular staining of IFN-γ in (C) CD4+ and (D) CD8+ T cells. Numbers indicate
percentage of cells in quadrants or gates.
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whether dysregulated cytokine production was observed in Ptenfl/flFoxp3-Cre:CD45.1+.
In the Ptenfl/flFoxp3-Cre:CD45.1+ mixed chimeras, IFN-J production from CD4+ and
CD8+ T cells was enhanced irrespective of the source of donor cells (Figure 3-15C
and D).
To determine the functional effects of the augmented IFN-J production, we
crossed Ptenfl/flFoxp3-Cre mice with Ifng–/– mice to generate Ptenfl/flFoxp3-Cre Ifng–/–
double knockout mice (Figure 3-16A). Deletion of IFN-J did not exert strong effects on
the production of IL-17 and IL-4 from the conventional CD4+ T cells
(Figure 3-16B and C). However, IFN-J deficiency substantially blocked the elevated
frequencies of TFH and GC B cells (Figure 3-17A and B) and the increased formation of
GCs in Ptenfl/flFoxp3-Cre mice (Figure 3-18). Moreover, the increased production of
serum ANA antibody and the deposition of IgG in the kidney glomeruli of Ptenfl/flFoxp3Cre mice were essentially rectified in Ptenfl/flFoxp3-Cre Ifng–/– mice
(Figures 3-19 and 3-20). Thus, the increased production of IFN-J in Ptenfl/flFoxp3-Cre
mice largely accounts for the exacerbated TFH, GC, and autoimmune responses, thereby
highlighting the crucial role of PTEN signaling in Treg cells to coordinate TH1 and TFH
reactions.
PTEN Is Crucial in Maintaining the Stability of Treg Cells
Despite the crucial role of IFN-J overproduction in disrupting immune
homeostasis in Ptenfl/flFoxp3-Cre mice, deletion of IFN-J did not affect the phenotype of
increased Treg cellularity in these mice (Figure 3-21A). We therefore explored the direct
effects of Pten deficiency on the homeostasis and functionality of Treg cells. As
compared with WT counterparts, Treg cells from Ptenfl/flFoxp3-Cre mice showed higher
expression of CD44 and CD69 but lower levels of CD62L, indicating an elevated level of
activation (Figure 3-22A). We next examined Treg-selective effector molecules.
Ptenfl/flFoxp3-Cre Treg cells showed increased levels of ICOS and PD-1, and to a lesser
extent, GITR, whereas the expression of CTLA4 was largely normal (Figure 3-22B). In
sharp contrast to the elevated expression of activation markers and effector molecules,
the expression of CD25, a signature molecule of Treg and activated T cells, was
markedly downregulated in Ptenfl/flFoxp3-Cre Treg cells, corresponding to the expansion
of the Foxp3+CD25– population (Figure 3-22C). As compared with Foxp3+CD25+ cells,
the Foxp3+CD25– population expressed lower levels of Foxp3, as reported previously
(Komatsu et al., 2009). Consistent with this observation, Blimp1, a transcription factor
implicated in CD25 downregulation in CD8+ T cells (Shin et al., 2013), was upregulated
in Ptenfl/flFoxp3-Cre Treg cells (Figure 3-22D). These results indicate that Pten
deficiency in Treg cells results in dysregulated expression of multiple Treg activation and
phenotypic molecules.
The lineage stability of Treg cells is a matter of considerable interest and debate
(Bailey-Bucktrout et al., 2013; Komatsu et al., 2014; Miyao et al., 2012; Rubtsov et al.,
2010; Tsuji et al., 2009; Zhou et al., 2009b), but the signaling mechanisms involved are
largely unexplored. To determine whether Pten deficiency affects the stability of Treg
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Figure 3-16. Generation and phenotypic analysis of Ptenfl/flFoxp3-Cre Ifng–/– mice.
Cytokine production of (A) IFN-γ, (B) IL-17 and (C) IL-4 by CD4+ T cells from WT,
Ptenfl/flFoxp3-Cre, Ifng–/– and Ptenfl/flFoxp3-Cre Ifng–/– mice after in vitro stimulation for
4 h with PMA plus ionomycin in the presence of monensin. Numbers indicate percentage
of cells in quadrants or gates.
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Figure 3-17. Uncontrolled TFH and GC B cells in Ptenfl/flFoxp3-Cre mice rescued in
Ptenfl/flFoxp3-Cre Ifng–/– mice.
Analysis of (A) TFH and (B) GC B cells in the spleen of WT, Ptenfl/flFoxp3-Cre, Ifng–/–
and Ptenfl/flFoxp3-Cre Ifng–/– mice. Numbers indicate percentage of cells in quadrants or
gates.

54

Figure 3-18. Immunochistochemistry of germinal centers in WT, Ptenfl/flFoxp3-Cre, Ifng–/– and Ptenfl/flFoxp3-Cre Ifng–/– mice.
(A) PNA staining of spleen sections (magnification, x2; scale bars, 2mm) and (B) immunofluorescence and quantification of MLN
sections for the staining of CD3 (red), PNA (green) and IgD (white) (scale 500 μm) from WT, Ptenfl/flFoxp3-Cre, Ifng–/– and
Ptenfl/flFoxp3-Cre Ifng–/– mice.
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Figure 3-19. Detection of antinuclear antibodies in WT, Ptenfl/flFoxp3-Cre, Ifng–/– and Ptenfl/flFoxp3-Cre Ifng–/– mice.
Representative images and quantification of fluorescent intensity of ANA IgG autoantibodies detected with Hep-2 slides in the serum
from WT, Ptenfl/flFoxp3-Cre, Ifng–/– and Ptenfl/flFoxp3-Cre Ifng–/– mice. (Scale 60 μm).
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Figure 3-20. Immunofluorescence analysis of glomeruli for IgG deposits in WT, Ptenfl/flFoxp3-Cre, Ifng–/– and Ptenfl/flFoxp3Cre Ifng–/– mice.
Representative images of immunofluorescence imaging of kidney sections showing IgG deposits (scale 300 μm), and quantitative
analysis (right) from WT, Ptenfl/flFoxp3-Cre, Ifng–/– and Ptenfl/flFoxp3-Cre Ifng–/– mice.
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Figure 3-21. Analysis of Treg cells in WT, Ptenfl/flFoxp3-Cre, Ifng–/– and
Ptenfl/flFoxp3-Cre Ifng–/– mice.
Flow cytometry analysis of (A) Treg (CD4+Foxp3+) cells and expression of (B) CD25
and Foxp3 (gated on CD4+TCRβ+ cells) in the spleen of WT, Ptenfl/flFoxp3-Cre, Ifng–/–
and Ptenfl/flFoxp3-Cre Ifng–/– mice. Numbers indicate percentage of cells in gates.
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Figure 3-22. Effects of Pten loss in Treg cells.
(A) Expression of CD44, CD69 and CD62L and (B) ICOS, PD-1, GITR and CTLA4 in
Treg cells from the spleen of WT and Ptenfl/flFoxp3-Cre mice, with mean fluorescence
intensity (MFI) plotted above graphs. (C) Expression of CD25 and Foxp3 (gated on
CD4+TCRβ+ cells) in the spleen of WT and Ptenfl/flFoxp3-Cre mice; numbers above
graphs indicate MFI of Foxp3 in CD25− and CD25+ subsets. Right, quantification of
Foxp3+CD25− cells. Numbers indicate percentage of cells in quadrants or gates. (D)
Expression of Blimp1 in splenic Treg cells of WT and Ptenfl/flFoxp3-Cre mice. Numbers
above graphs indicate MFI of Blimp1. **P < 0.001. Data are mean ± s.e.m.

59

cells, we crossed Ptenfl/flFoxp3-Cre mice with a Cre recombination-sensitive reporter
allele, in which the ubiquitously expressed ROSA26 locus contains a loxP site–flanked
STOP cassette followed by the gene encoding green fluorescent protein (GFP) (Zeng et
al., 2013). In this lineage tracing system, Foxp3-Cre-mediated excision of the floxed
STOP cassette results in constitutive, heritable expression of GFP, even for those “exTreg” cells that have lost Foxp3 expression (the GFP+YFP-Foxp3– population).
Ptenfl/flFoxp3-Cre mice contained a notable accumulation of the GFP+YFP-Foxp3–
population (Figure 3-23A), indicating the preferential loss of Foxp3 expression upon
Pten deletion. Additionally, Treg cells from Ptenfl/flFoxp3-Cre mice had increased
expression of IFN-J, whereas IL-17 expression was largely unaltered
(Figure 3-24A and B).
Moreover, Pten-deficient Treg cells upregulated signature molecules
characteristic of TH1 and TFH cells, including CXCR3 and T-bet, and CXCR5 and Bcl6,
respectively, whereas expression of IRF4 and p-STAT3, which are required for Treg cellmediated suppression of TH2 and TH17 cells (Chaudhry et al., 2009; Zheng et al., 2009),
remained unchanged (Figure 3-24C) Consistent with these observations, Pten-deficient
Treg cells contained an expanded T-bet+CXCR3+ population that is important for the
regulation of type 1 inflammation (Figure 3-24D) (Koch et al., 2009). Because the
development of this Treg cell subset is dependent upon IFN-J signaling (Koch et al.,
2009), we examined whether excessive IFN-J production in Ptenfl/flFoxp3-Cre mice was
involved in the dysregulation of T-bet and CXCR3. IFN-J deficiency had a partial rescue
effect on the expansion of T-bet+CXCR3+ population in Pten-deficient Treg cells
(Figure 3-24D), indicating that the augmented expression of T-bet and CXCR3 upon loss
of Pten is largely cell intrinsic, not simply secondary to the overproduction of IFN-J.
Finally, to directly test the role of PTEN in maintaining Treg stability, we sorted
Foxp3+CD25+ cells from WT and Ptenfl/flFoxp3-Cre mice and transferred them into
congenic mice (CD45.1+). The expression of Foxp3 and CD25 was downregulated in
Pten-deficient Treg cells in various organs examined, as compared with WT cells
(Figure 3-23B and C). These complementary approaches indicate that Pten deficiency
results in a loss of Treg stability.
Notably, despite the strong effects of IFN-J at disrupting immune homeostasis,
deletion of IFN-J in Ptenfl/flFoxp3-Cre mice did not affect the spontaneous development
of the Foxp3+CD25– population (Figure 3-21B). Thus, the enhanced IFN-J expression
from Pten-deficient Treg cells is associated with the loss of Treg cell stability, but this
cytokine is unlikely to be the main driver of instability.
PTEN Is Haploinsufficient in Treg Cells
Given the potent effects of PTEN signaling in Treg cells, we asked whether
partial loss of PTEN function in Treg cells is physiologically relevant, by analyzing
Ptenfl/+Foxp3-Cre mice. As expected, Ptenfl/+Foxp3-Cre Treg cells, but not other T cell
subsets, had partial reduction of PTEN expression at both the mRNA and protein levels
(Figure 3-25A and B). Remarkably, heterozygous loss of Pten resulted in the expansion
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Figure 3-23. Pten deficiency impairs Treg cell stability.
(A) Foxp3-YFP and GFP expression in CD4+ T cells from Pten+/+Foxp3Cre Rosa26GFP and Ptenfl/flFoxp3-Cre Rosa26GFP mice. (B) Left, donor cell percentages
(top) and Foxp3 and CD25 expression (bottom) in WT and Ptenfl/flFoxp3-Cre
Treg (CD45.2+) cells transferred into CD45.1+ recipients. Right, expression of Foxp3 and
CD25 from donor-derived WT and Ptenfl/flFoxp3-Cre T cells; numbers above graphs
indicate MFI. (C) Analysis of Foxp3 (top) and CD25 (bottom) expression in PLNs and
MLNs of CD45.1+ recipients after transferring WT and Ptenfl/flFoxp3-Cre Treg (CD45.2+)
cells. Numbers above graphs indicate MFI. Numbers indicate percentage of cells in
quadrants or gates.
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Figure 3-24. Analysis of Treg cells in Ptenfl/flFoxp3-Cre Ifng−/− mice and
Ptenfl/flFoxp3-Cre Treg cell phenotypes under steady state.
(A) Expression of IFN-γ and IL-17 (right, quantification of IFN-γ+ and IL-17+ producing
cells in Treg cells) (B) Analysis of Ifng RNA in Treg cells of WT and Ptenfl/flFoxp3-Cre
mice. (C) Expression of CXCR3, CXCR5, T-bet, Bcl6, IRF4 and p-Stat3 in Treg cells
from the spleen of WT and Ptenfl/flFoxp3-Cre mice. (D) Analysis of CXCR3 and T-bet
expression in Treg cells in the spleen of WT, Ptenfl/flFoxp3-Cre, Ifng−/− and
Ptenfl/flFoxp3-Cre Ifng−/− mice. Data are mean ± s.e.m. *P < 0.05 and **P < 0.001.
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Figure 3-25. Pten expression and immune dysregulation in Ptenfl/+Foxp3-Cre mice.
Analysis of (A) Pten mRNA and (B) protein expression in Treg, naïve CD4+
(CD62L+CD44−), and CD8+ T cells from WT and Ptenfl/+Foxp3-Cre mice. Numbers
below the PTEN lanes in (B) indicate band intensity relative to that of β-actin. (C)
Immunofluorescence of spleen sections of WT and Ptenfl/+Foxp3-Cre mice for the
staining of CD3 (red) and PNA (green) showing germinal center (scale 60 μm). Right,
quantification of germinal center area. (D) Images of peripheral lymph nodes from WT
and Ptenfl/+Foxp3-Cre mice (~5 months old) with lymphoproliferative disease. Data are
mean ± s.e.m. *P < 0.05.
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of Treg cells, associated with the considerable downregulation of CD25 expression
(Figure 3-26A). Ptenfl/+Foxp3-Cre mice also showed a notable accumulation of
GFP+YFP-Foxp3– population in the lineage tracing system (Figure 3-26B). Moreover,
these mice had higher frequencies of CXCR5+PD-1+ TFH cells and GL7+CD95+ GC B
cells (Figure 3-26C), and a greater abundance of GCs in the spleen (Figure 3-25C).
These findings prompted us to examine whether heterozygous loss of Pten in Treg cells
caused autoimmunity and lymphoid hyperplasia as observed in Ptenfl/flFoxp3-Cre mice.
Ptenfl/+Foxp3-Cre mice displayed significantly elevated titers of circulating ANA
antibodies (Figure 3-27) and augmented IgG deposits in the kidney glomeruli
(Figure 3-28), indicative of systemic autoimmunity. Furthermore, Ptenfl/+Foxp3-Cre
mice spontaneously developed lymphoadenopathy (Figure 3-25D). These results
demonstrate that PTEN is haploinsufficient in Treg cells.
Summary
In this chapter, we used conditional knockout mice with Pten specifically deleted
in Treg cells to explore its functional relevance in vivo. We have highlighted Tregspecific loss of Pten results in higher frequency of activated CD44hi T cells and Treg
cells. Additionally, excessive TFH responses (CXCR5+PD1+CD4+ T cells) and
spontaneous formation of germinal centers (detected with PNA staining and
immunofluorescence assay) was also seen in steady state. Increased TFH and germinal
center reactions were also evident in Ptenfl/flFoxp3-Cre after using SRBC or NP-OVA
immunization. Loss of Pten in Treg cells was sufficient to induce the development of
systemic autoimmune and lymphoproliferative disease, as determined by histological
analyses, autoantibody (dsDNA and ANA) detection, and immunofluorescence of IgG
deposits in kidney. Furthermore, deletion of IFN-J considerably blocked such immune
dysregulation, indicating the coordinated control of TH1 and TFH responses by PTEN
signaling in Treg cells (investigated using Ptenfl/flFoxp3-Cre Ifng–/– double knockout
mice). Using lineage tracing and in vivo transfer models, we elucidated the underlying
mechanisms by showing that deletion of Pten resulted in instability of Treg cells, featured
by decreased expression of CD25 and Foxp3 expression. Finally, we presented evidence
that PTEN is haploinsufficient in Treg cells. Together, the findings shown in this chapter
have established the necessity of PTEN signaling in Treg cells for normal immune
tolerance.
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Figure 3-26. Heterozygous loss of Pten in Treg cells is sufficient to disrupt immune homeostasis.
(A) Flow cytometry analysis of Foxp3 and CD25 expression in WT and Ptenfl/+Foxp3-Cre splenic CD4+ T cells. (B) Foxp3-YFP and
GFP expression in CD4+ T cells from Pten+/+Foxp3-Cre Rosa26GFP and Ptenfl/+Foxp3-Cre Rosa26GFP mice. (C) Analysis of
CXCR5+PD-1+ cells (gated on CD4+TCRβ+ cells) and GL7+CD95+ GC B cells (gated on CD19+ B cells) in the spleen of WT and
Ptenfl/+Foxp3-Cre mice. Numbers indicate percentage of cells in gates.
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Figure 3-27. Detection of antinuclear antibodies in WT and Ptenfl/+Foxp3-Cre mice.
Representative images (scale bars, 60 μm) and quantification of fluorescent intensity (right) of serum anti-ANA IgG detected with
fixed Hep-2 slides in WT and Ptenfl/+Foxp3-Cre mice. Data are mean ± s.e.m. *P < 0.001.

66

Figure 3-28. Immunofluorescence analysis of glomeruli for IgG deposits in WT and Ptenfl/+Foxp3-Cre mice.
Immunofluorescence (left) and quantification (right) of IgG deposits in kidney glomerulus sections (scale bars, 100 μm) from WT and
Ptenfl/+Foxp3-Cre mice. Data are mean ± s.e.m. *P < 0.0001.
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CHAPTER 4.

MOLECULAR AND METABOLIC MECHANISMS OF PTEN
SIGNALING*

In this chapter, we aimed to characterize the mechanisms underlying Ptendeficient Treg cell dysfunction and stability described in Chapter 3. Mechanistically, Pten
deficiency results in dysregulated transcriptional and metabolic programs, including the
balance between glycolytic activity and mitochondrial fitness. Further, mTORC2, not
mTORC1 activity, is upregulated by Pten deletion in Treg cells. Depletion of RictormTORC2 activity is sufficient to restore the functional abnormalities observed in Ptendeficient Treg cells. Additionally, retention of mTORC2 downstream target Foxo1 in the
nucleus seems to abrogate the effects of PTEN loss in Treg cells. Our studies presented in
this chapter establish a crucial role of the PTEN-mTORC2 axis in mediating Treg cell
stability and homeostasis of the immune system.
PTEN-dependent Transcriptional and Metabolic Programs in Treg Cells
To explore PTEN-dependent molecular mechanisms in Treg cells, we next used
microarrays to compare the transcriptional profiles between WT and Ptenfl/flFoxp3-Cre
Treg cells. Ptenfl/flFoxp3-Cre Treg cells contained a total of 498 probes (representative of
352 unique genes) with a greater than 1.5-fold difference, including 212 upregulated and
286 downregulated probes. Principal component analysis (PCA) showed the clear
distinctions between WT and Ptenfl/flFoxp3-Cre samples (Figure 4-1A). Consistent with
the dysregulated stability, loss of Pten failed to restrain the transcription of genes
involved in TFH differentiation, including Gzmb, Il21, Bcl6, Pdcd1, Il4, Maf and Cxcr5
(Crotty, 2011; Wang et al., 2014) (Figure 4-2). To identify key networks regulated by
PTEN, we performed gene-set enrichment analysis (GSEA) (Subramanian et al., 2005) to
compare gene expression profiles of WT and Pten-deficient Treg cells. Remarkably, the
top-ten, upregulated gene-sets in Ptenfl/flFoxp3-Cre Treg cells were all associated with
cell cycle pathways (Figure 4-1B and C). To examine PTEN-dependent canonical
pathways in Treg cells, we next performed the ingenuity pathway analysis (IPA) system
by interrogating the differentially expressed genes at the 1.5-fold cut-offs. As shown in
Figure 4-3, Pten deficiency affected multiple canonical pathways implicated in
autoimmune diseases, helper T cell differentiation, and immune signaling mediated by
transcription factors, co-stimulatory molecules and cytokines. Gene ontology (GO)
analysis of these differentially regulated genes also showed that Pten-deficient Treg cells
significantly upregulated groups of genes involved in autoimmune diseases, such as
autoimmune thyroid disease and SLE, as well as in cell cycle regulation (Supplementary
Data 1 – Gene Ontology Analysis of Pten-deficient Treg Mice). The transcriptome
analysis therefore highlights an important role of PTEN in the regulation of immune
response and cell cycle pathways.
-----------------------*Chapter 4 reprinted with permission. Shrestha, S., Yang, K., Guy, C., Vogel, P., Neale,
G., and Chi, H. (2015). Treg cells require the phosphatase PTEN to restrain TH1 and TFH
cell responses. Nature immunology 16, 178-187.

68

Figure 4-1. The transcriptional profiles controlled by Pten in Treg cells.
(A) PCA mapping of WT and Ptenfl/flFoxp3-Cre Treg cells. (B) GSEA reveals the cell
cycle mitotic pathway as one of the most extensively upregulated pathways in
Ptenfl/flFoxp3-Cre Treg cells. (C) The list of top 10 gene sets upregulated in
Ptenfl/flFoxp3-Cre Treg cells by GSEA. NES, normalized enrichment score.
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Figure 4-2. PTEN-dependent gene expression analysis.
Heat map of expression of TFH genes related upregulated in Ptenfl/flFoxp3-Cre mice,
relative to the WT mean (≥1.5-fold).
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Figure 4-3. Ingenuity pathway analysis (IPA) of the differentially expressed genes
in Ptenfl/flFoxp3-Cre Treg cells.
IPA of canonical pathways controlled by Pten in Treg cells, differentially expressed
genes at the 1.5-fold cut-offs.
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Cellular metabolic programs, especially glycolysis and mitochondrial oxidative
phosphorylation, play an important role in shaping Treg cell generation and function
(Michalek et al., 2011a; Shi et al., 2011), although the molecular mechanisms are
unknown. As compared with WT Treg cells, Pten-deficient Treg cells more strongly
upregulated glycolysis after TCR/CD28 stimulation (Figure 4-4A). We next examined
whether Pten deficiency affects mitochondrial fitness by measuring multiple parameters
associated with mitochondria homeostasis and functions. Pten-deficient Treg cells
showed considerable reductions of reactive oxidative species (ROS), mitochondrial mass,
and mitochondrial membrane potential, indicative of impaired mitochondrial fitness
(Figure 4-4B). Notably, the reductions of these parameters was more prominent in Ptendeficient Foxp3+CD25– Treg cells than Foxp3+CD25+ Treg cells (Figure 4-4B),
indicating that impaired mitochondrial function is associated with Treg cell instability.
Moreover, the Foxp3+CD25– Treg subset had modestly increased BrdU incorporation
than Foxp3+CD25+ cells (Figure 4-4C). Altogether, these data establish that PTEN
signaling links immune response gene expression, cell cycle progression, and metabolic
balance between glycolytic activity and mitochondrial fitness in Treg cells.
PTEN Restrains mTORC2 Activity in Treg Cells
We next determined PTEN-dependent biochemical mechanisms in Treg cells by
examining mTORC1 and mTORC2 activities, as both are under the control of PTEN in
multiple cell types (Chi, 2012). In response to short-term anti-CD3-CD28 stimulation (515 min), Ptenfl/flFoxp3-Cre Treg cells exhibited slightly elevated phosphorylation of the
mTORC1 target S6, as compared with WT Treg cells (Figures 4-5A and 4-6A). In
contrast, Ptenfl/flFoxp3-Cre Treg cells exhibited much stronger activation of mTORC2
signaling than WT cells, as indicated by the enhanced phosphorylation of AKT at Ser473
and of the AKT substrate, Foxo1 (Figure 4-5A). We next determined the effects of
stimulating Treg cells with anti-CD3-CD28 for a longer time (20 h), in the presence or
absence of IL-2. Both WT and Pten-deficient Treg cells responded to these stimuli with
robust phosphorylation of S6 and 4EBP1, indicative of comparable activation of the
mTORC1 pathway under these conditions (Figures 4-5B and 4-6B). In contrast,
Ptenfl/flFoxp3-Cre Treg cells exhibited much stronger activation of mTORC2 signaling
than WT cells (Figure 4-5B). Therefore, loss of PTEN results in preferential activation of
mTORC2 signaling in Treg cells.
To determine the contribution of mTORC2 activity to the phenotypes of
Ptenfl/flFoxp3-Cre mice, we generated mice bearing Treg cells with a double deletion of
Pten and the mTORC2 obligate adaptor Rictor (termed Ptenfl/flRictorfl/flFoxp3-Cre mice),
since Rictor is an essential regulator of mTORC2 activity in Treg cells (Zeng et al.,
2013). In contrast to the phenotype observed in Ptenfl/flFoxp3-Cre mice, Treg cells in
Ptenfl/flRictorfl/flFoxp3-Cre mice exhibited normal abundance and CD25 expression
(Figure 4-7). Other Treg cell markers analyzed were also considerably rescued by the
deletion of Rictor from Ptenfl/flFoxp3-Cre Treg cells (Figure 4-8A). Additionally, T cells
in Ptenfl/flRictorfl/flFoxp3-Cre mice exhibited largely normal distribution of naïve and
effector/memory phenotypes (Figure 4-8B). Also, the spontaneous development of TFH
and TH1 cells and GC B cells observed in Ptenfl/flFoxp3-Cre mice was blocked by
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Figure 4-4. PTEN-dependent metabolic programs in Treg cells.
(A) Glycolytic activity of Treg cells stimulated with α-CD3-CD28. (B) ROS production,
mitochondrial mass and mitochondrial membrane potential in Treg cells of WT and
Ptenfl/flFoxp3-Cre mice. Numbers above graphs indicate mean fluorescence intensity
(MFI). (C) BrdU incorporation in Treg subsets of WT and Ptenfl/flFoxp3-Cre mice.
Numbers indicate percentage of cells in gates.
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Figure 4-5. Dysregulation of mTORC2 activity in Pten-deficient Treg cells.
Immunoblot analysis of (A) p-Akt(S473), p-Foxo1 and p-S6 in resting and short-term–
stimulated and (B) long-term–stimulated Treg cells isolated from WT and Ptenfl/flFoxp3Cre mice.
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Figure 4-6. Analysis of Pten expression in short and long term stimulated Treg
cells.
(A) Pten expression in resting and short-term stimulated Treg cells and (B)
phosphorylation of 4E-BP1 and Pten in resting and long-term stimulated Treg cells
isolated from WT and Ptenfl/flFoxp3-Cre mice.
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Figure 4-7. Analysis of Treg cells in Ptenfl/flFoxp3-Cre and Ptenfl/flRictorfl/flFoxp3Cre mice under steady state.
Flow cytometry analysis of WT, Ptenfl/flFoxp3-Cre, Rictorfl/flFoxp3-Cre and
Ptenfl/flRictorfl/flFoxp3-Cre mice for (A) Foxp3 and (B) CD25 expression in CD4+ T cells.
Numbers indicate percentage of cells in gates.
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Figure 4-8. Pten represses mTORC2 signaling in Treg cells to maintain immune homeostasis.
(A) Expression of CD69, CD62L, CXCR5, ICOS and PD-1, and measurements of ROS, mitochondrial mass, and mitochondrial
membrane potential (TMRM) in Treg cells from the spleen of WT, Ptenfl/flFoxp3-Cre, Rictorfl/flFoxp3-Cre and Ptenfl/flRictorfl/flFoxp3Cre mice. (B) Flow cytometry analysis of WT, Ptenfl/flFoxp3-Cre, Rictorfl/flFoxp3-Cre and Ptenfl/flRictorfl/flFoxp3-Cre mice for CD62L
and CD44 expression on CD4+ and CD8+ T cells and, (C) cytokine production of CD4+ T cells.
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Rictor deletion (Figures 4-9 and 4-8C). Moreover, unlike Ptenfl/flFoxp3-Cre mice,
Ptenfl/flRictorfl/flFoxp3-Cre mice did not contain IgG deposits in the kidney glomeruli
(Figure 4-10), and exhibited normal GC numbers in the spleen and MLNs
(Figure 4-11A and B). Therefore, despite the plethora of pathways identified to mediate
PTEN functions in various cells (Chi, 2012), PTEN acts in a mTORC2-dependent
manner in Treg cells to impinge upon immune homeostasis and tolerance.
Nuclear Retention of Foxo1 Abrogates the Effects of PTEN Loss
Activation of AKT by mTORC2 leads to phosphorylation of transcription factor
Foxo1 that interacts with Foxp3 and is critical for Treg cell lineage maintenance (Harada
et al., 2010; Kerdiles et al., 2010; Ouyang et al., 2009; Ouyang et al., 2010; Ouyang et al.,
2012). To determine the contribution of mTORC2-AKT-mediated inhibition of Foxo1
activity t to the phenotypes of Ptenfl/flFoxp3-Cre mice, we crossed Ptenfl/flFoxp3-Cre
mice with those expressing the one allele of Foxo1AAA mutant to generate Ptenfl/fl
Foxo1AAA/+Foxp3-Cre. This mutant is constitutively localized to the nucleus, as it lacks
the inhibitory AKT phosphorylation sites (Ouyang et al., 2012). Importantly, the
Foxo1AAA heterozygous mice were selected for analysis, as homozygous mice are prone
to wasting disease (Luo et al., 2016).
In preliminary experiments, ectopic expression of Foxo1AAA ameliorated several
phenotypic characteristics, such as the altered distribution of naive and effector or
memory and increased IFN-γ production seen in T cells from Ptenfl/flFoxp3-Cre mice
(Figure 4-12A and B). Additionally, expression of Foxo1AAA substantially dampened the
aberrant TFH and GC B cell responses of Ptenfl/flFoxp3-Cre mice (Figure 4-13).
Moreover, no visible lymphadenopathy (unpublished observations) and rectified ANA
levels (Figure 4-14), indicates absence of lymphoproliferative disease in Ptenfl/fl
Foxo1AAA/+Foxp3-Cre mice. Interestingly, the high frequency of CD4+YFP+ and CD25YFP+ Treg cells were still seen in Ptenfl/fl Foxo1AAA/+Foxp3-Cre mice (Figure 4-15).
Therefore, despite Foxo1 being a downstream target of mTORC2-AKT, the data
presented above indicates alternative downstream targets control Treg cell cellularity and
stability, which needs to be further studied.
Summary
In this chapter, we highlighted PTEN orchestrates transcriptional programs and
the metabolic balance between glycolysis and mitochondrial fitness to support Treg cell
function. Phenotypic observations of abnormalities we characterized in Chapter 3 due
were attributed to dysregulated activation of the mTORC2-mediated pathway, as
generation of Ptenfl/flRictorfl/flFoxp3-Cre mice ameliorated those defects. Further, these
defects were linked to excessive inactivation of Foxo1, because expression of the AKTinsensitive FoxoAAA mutant also alleviated several features of disease seen in
Ptenfl/flFoxp3-Cre mice. However, the higher frequency and instability of Treg cells still
remained consistent, which indicated involvement of additional alternative targets
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Figure 4-9. Analysis of TFH and GC B cells in Ptenfl/flFoxp3-Cre and
Ptenfl/flRictorfl/flFoxp3-Cre mice under steady state.
Flow cytometry analysis of WT, Ptenfl/flFoxp3-Cre, Rictorfl/flFoxp3-Cre and
Ptenfl/flRictorfl/flFoxp3-Cre mice for proportions of (A) TFH cells in CD4+ T cells and (B)
GC B cells in total B cells. Numbers indicate percentage of cells in gates.

79

Figure 4-10. Immunofluorescence analysis of glomeruli for IgG deposits in WT, Ptenfl/flFoxp3-Cre, Rictorfl/flFoxp3-Cre and
Ptenfl/flRictorfl/flFoxp3-Cre mice.
Imaging (left) and quantification (right) of IgG deposits in kidney sections of WT, Ptenfl/flFoxp3-Cre, Rictorfl/flFoxp3-Cre and
Ptenfl/flRictorfl/flFoxp3-Cre mice (scale bars, 300 μm).
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Figure 4-11. Immunochistochemistry of germinal centers in WT, Ptenfl/flFoxp3-Cre, Rictorfl/flFoxp3-Cre and
Ptenfl/flRictorfl/flFoxp3-Cre mice.
(A) PNA staining of spleen sections (magnification, x2; scale bars, 2mm) and (B) immunofluorescence and quantification of MLN
sections for the staining of CD3 (red), PNA (green) and IgD (white) (scale 500 μm) from WT, Ptenfl/flFoxp3-Cre, Rictorfl/flFoxp3-Cre
and Ptenfl/flRictorfl/flFoxp3-Cre mice.
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Figure 4-12. Analysis of Ptenfl/flFoxp3-Cre and Ptenfl/fl Foxo1AAA/+Foxp3-Cre mice
under steady state.
(A) Flow cytometry analysis of WT, Ptenfl/flFoxp3-Cre, Foxo1AAA/+Foxp3-Cre and
Ptenfl/fl Foxo1AAA/+Foxp3-Cre mice for CD62L and CD44 expression on CD4+ and CD8+
T cells and, (B) IFN-γ production of by CD4+ and CD8+ T cells.
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Figure 4-13. Analysis of TFH and GC B cells in Ptenfl/flFoxp3-Cre and Ptenfl/fl
Foxo1AAA/+Foxp3-Cre mice under steady state.
Flow cytometry analysis of WT, Ptenfl/flFoxp3-Cre, Foxo1AAA/+Foxp3-Cre and Ptenfl/fl
Foxo1AAA/+Foxp3-Cre mice for proportions of (A) TFH cells in CD4+ T cells and (B) GC
B cells in total B cells. Numbers indicate percentage of cells in gates.
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Figure 4-14. Detection of antinuclear antibodies in WT, Ptenfl/flFoxp3-Cre, Foxo1AAA/+Foxp3-Cre and Ptenfl/fl
Foxo1AAA/+Foxp3-Cre mice.
Representative images (scale bars, 50 μm) and quantification of fluorescent intensity (right) of serum anti-ANA IgG detected with
fixed Hep-2 slides in WT, Ptenfl/flFoxp3-Cre, Foxo1AAA/+Foxp3-Cre and Ptenfl/fl Foxo1AAA/+Foxp3-Cre mice.
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Figure 4-15. Analysis of Treg cells in Ptenfl/fl Foxo1AAA/+Foxp3-Cre mice under
steady state.
Flow cytometry analysis of WT, Ptenfl/flFoxp3-Cre, Foxo1AAA/+Foxp3-Cre and Ptenfl/fl
Foxo1AAA/+Foxp3-Cre mice for (A) Foxp3 and (B) CD25 expression in CD4+ T cells.
Numbers indicate percentage of cells in gates.
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downstream of mTORC2-AKT pathway for Treg cell programming. To summarize, we
have established a new paradigm that the interplay between immune signaling and
metabolic activity links Treg cell stability. At the molecular levels, PTEN orchestrates
Treg stability and functional diversity by impinging upon the metabolic balance and
mTORC2 signaling.
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CHAPTER 5.

DISCUSSION*

Much emphasis has been placed on the transcriptional and molecular pathways
underlying effector T cell diversity and plasticity (Zhu et al., 2010). In contrast, how
these distinct effector T cell responses are controlled by extrinsic mechanisms is poorly
understood. Moreover, despite the emerging evidence for the adoption of TH-specific
transcription factors by Treg cells to suppress the corresponding effector responses
(Chaudhry et al., 2009; Koch et al., 2009; Zheng et al., 2009), we have little
understanding about the signaling mechanisms in Treg cells that program and coordinate
these suppressive activities. Our studies identify PTEN as an important molecular
pathway in Treg cells that coordinately regulates TFH and TH1 responses (Figure 5-1).
Our findings are consistent with the results reported by our colleagues, Huynh et al.
(Huynh et al., 2015). In particular, loss of Pten in Treg cells results in exacerbated TFH
and GC responses and the loss of immune tolerance and tissue homeostasis. Using
genetic approaches to ablate IFN-J function, we have revealed the hierarchy between
Treg cell-mediated control of TH1 and TFH responses, with the production of the TH1
signature cytokine IFN-J a prerequisite for the potentiation of TFH responses
Ptenfl/flFoxp3-Cre mice. Furthermore, the repression of TH1 and TFH responses is
associated with the active maintenance of Treg cell stability mediated by PTEN
signaling. At the molecular levels, PTEN controls the transcriptional program and
metabolic balance in Treg cells, and signals mainly via inhibition of mTORC2 activity.
Further, our data suggests PTEN-dependent mTORC2 inhibition is important to maintain
the appropriate balance of Foxo1 function in Treg cells. Our studies therefore establish
that the PTEN-mTORC2 signaling axis acts as a central pathway to enforce Treg cell
stability and further links it to the control of TH1 and TFH responses. Loss of this control
mechanism is detrimental to immune homeostasis and tolerance, highlighting the
physiological significance of this new control mechanism.
The lineage stability of Treg cells remains contentious (Bailey-Bucktrout et al.,
2013; Komatsu et al., 2009; Komatsu et al., 2014; Miyao et al., 2012; Rubtsov et al.,
2010; Tsuji et al., 2009; Zhou et al., 2009b) but is an issue of utmost importance, as it
directly impinges upon Treg cell-mediated control of health and disease and therapeutic
strategies (Sakaguchi et al., 2013). Part of the controversies stem from the limited
understanding of the underlying molecular processes, despite the extensive research on
the regulation of Foxp3 itself. Using lineage tracing and adoptive transfer systems, we
show that Pten-deficient Treg cells are more prone to lose Foxp3 expression in vivo.
However, Pten deficiency results in apparently hyper-activated Treg cells, as evidenced
by increased cycling, upregulation of activation and phenotypic markers, and
dysregulated expression of IFN-J and other TH1 and TFH signature molecules. Consistent
-----------------------*Chapter 5 reprinted with permission. Shrestha, S., Yang, K., Guy, C., Vogel, P., Neale,
G., and Chi, H. (2015). Treg cells require the phosphatase PTEN to restrain TH1 and TFH
cell responses. Nature immunology 16, 178-187.
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Figure 5-1. Schematics of PTEN signaling in Treg cell functions and immune tolerance.
Loss of PTEN in Treg cells dysregulates mTORC2 signaling and metabolic and transcriptional programs, leading to the disrupted
stability of Treg cells (as evidenced by the downregulation of CD25 expression, as well as other abnormalities not depicted here).
Associated with loss of Treg cell stability and the ensuing TH1 responses and IFN-J production is the aberrant induction of TFH
responses, spontaneous formation of germinal center responses, and development of autoimmune and lymphoproliferative disease.
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with the hyper-activation of Treg cells, Pten deletion results in marked loss of CD25
expression, which is normally downregulated in Treg cells after in vivo activation and
proliferation (Gavin et al., 2002).
While representing only a minor proportion of Foxp3+ Treg cells under steady
state, the Foxp3+CD25– population likely makes an important contribution, via
conversion or selection, to the generation of ex-Treg cells under inflammatory or
lymphopenic environment. Therefore, our studies highlight that the stability of Treg cells
under steady state requires active enforcement by PTEN, which functions, at least in part,
by preventing overt Treg cell activation and CD25 downregulation.
Both mTOR complexes plays an important role in maintenance of Treg cells, as
dysregulated mTORC1 signaling results in unstable Treg cells giving rise to TH17-like
effector T cells (Park et al., 2013), suggesting a dominant role of the PI3K-PDK1
pathway on Treg stability and function (Wei et al., 2016). Our results showing instability
of Treg cells and phenotypes associated with TH1 cells due to loss of PTEN is mTORC2mediated. As PIP3 has been linked to direct activation of mTORC2 (Gan et al., 2011; Liu
et al., 2015), the results we obtained seem to be independent of PDK1-associated
activation.
The generation of TFH cells, the specialized providers of help to B cells, requires
unique transcriptional programs and is antagonized by TFR cells (Chung et al., 2011;
Linterman et al., 2011). However, TFR cells can also promote antigen-specific highaffinity B cell responses (Linterman et al., 2011) and influenza-specific GC reactions
(Leon et al., 2014). Extensive crosstalk also exists between the differentiation of TFH cells
and other effector lineages (Crotty, 2011), although the involvement of Treg cells in these
processes remains largely unexplored. Here we show that PTEN signaling in Treg cells is
crucial in the repression of TFH responses, and this is further linked to Treg cell stability
and Treg cell-mediated control of TH1 responses. Strikingly, loss of PTEN in Treg cells
results in spontaneous TFH differentiation and GC formation, and the development of
SLE-like autoimmune symptoms. These immune defects are associated with dysregulated
expression of many genes involved in TFH and TFR responses in Pten-deficient Treg cells.
Furthermore, the uncontrolled TFH responses in Ptenfl/flFoxp3-Cre mice are dependent
upon the TH1 signature cytokine IFN-J, as deletion of IFN-J considerably rectifies the
dysregulated TFH response and autoimmune disease. Notably, the relationship between
TH1 and TFH cells is complex and remains controversial. For instance, whereas IFN-J is
essential in driving TFH cells in the Roquinsan/san autoimmunity model (which has a point
mutation in the Roquin gene) (Lee et al., 2012a), it is dispensable for the differentiation
of TFH cells induced by viral infection (Ray et al., 2014). Further, T-bet induction
dampens rather than enhances the TFH differentiation program (Nakayamada et al., 2011).
Our studies demonstrate that TFH and TH1 responses are coordinately regulated by Treg
cells, with the TH1-mediated IFN-J production being a main driver of TFH and GC
reactions. However, we cannot conclude the direct contribution of the exacerbated TH1
response, independent of TFH cells, to the autoimmune and lymphoproliferative
phenotypes.
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As one of the most frequently mutated tumor suppressor genes, PTEN is
implicated in the regulation of multiple cancer types. Selective deletion of PTEN in T
cells results in rapid development of T cell leukemia, as well as the loss of immune
tolerance (Suzuki et al., 2001). More recent studies unveil that these two effects can be
dissociated, as they are derived from abnormalities in the thymus and periphery,
respectively (Liu et al., 2010). PTEN is also implicated in the regulation of effector T cell
responses. Deletion of Pten in activated T cells enhances effector responses but does not
lead to autoimmunity or cancer (Soond et al., 2012). miRNAs targeting PTEN expression
are also implicated in shaping TFH responses (Kang et al., 2013). In Treg cells, PTEN
expression is maintained at a higher level than conventional T cells (Zeiser et al., 2008).
PTEN restrains the abundance of Treg cells but is largely dispensable for Treg cell
suppressive activity in vitro (Walsh et al., 2006). We found that deletion of Pten in Treg
cells leads to the exacerbated effector T cell responses and loss of immune tolerance and
tissue homeostasis. Pten-deficient Treg cells dominate over WT cells in mediating TFH
and GC responses, which are mediated, at least in part, by dysregulated IFN-J expression.
Moreover, PTEN functions in a haploinsufficient manner, in that heterozygous loss of
Pten is sufficient to disrupt Treg cell and immune homeostasis. These results together
establish PTEN signaling in Treg cells as a unique regulator of immune system
homeostasis and function.
How does PTEN function in Treg cells at the molecular levels? Our microarray,
metabolic and immunological assays reveal the important role of PTEN in linking cell
cycle and metabolic machineries and the expression of immune effector genes in Treg
cells. Given the opposing effects of glycolytic and mitochondrial metabolism on Treg
cells (Michalek et al., 2011a; Shi et al., 2011), the disrupted balance between these
activities in Pten-deficient Treg cells is likely an important contributor to the phenotypic
alteration, a notion that we are currently investigation. Of note, despite the metabolic
functions of PTEN and PI3K signaling identified in non-immune cells, the underlying
mechanisms are highly complex and poorly understood (Garcia-Cao et al., 2012). For
instance, PTEN can either potentiate or inhibit mitochondrial activity (Garcia-Cao et al.,
2012; Li et al., 2013), and the metabolic functions of PTEN are associated with both
mTORC1-dependent and independent activities (Garcia-Cao et al., 2012; Song et al.,
2011; Tandon et al., 2011). Indeed, various effector pathways downstream of PTEN have
been identified, including PI3K-AKT, mTORC1, mTORC2, and PI3K-AKT-independent
nuclear functions (Chi, 2012; Garcia-Cao et al., 2012; Newton and Turka, 2012; Shen et
al., 2007; Song et al., 2011). It is therefore unexpected that our biochemical and genetic
rescue experiments have identified mTORC2 signaling as a dominant mechanism to
mediate PTEN functions in Treg cells. Emerging evidence highlights a crucial role of
mTOR and metabolic signaling in Treg cells, which was believed to mainly function as a
negative regulator of Treg cells (Delgoffe et al., 2009). However, recent genetic studies
indicate that both loss and gain of mTORC1 activity are detrimental to Treg-mediated
suppressive function and immune tolerance (Park et al., 2013; Wei et al., 2016; Zeng et
al., 2013). In contrast, the physiological significance and regulatory mechanisms of
mTORC2 are much less clear. Here our results have established the PTEN-mTORC2 axis
as a central determinant of Treg cell stability and Treg cell-mediated control of effector T
cell responses. Mechanistically, this signaling pathway likely orchestrates and
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coordinates both the metabolic and transcriptional programs, such as those mediated by
Foxo1 and Blimp1 (Ouyang et al., 2012; Shin et al., 2013), in impinging upon Treg
stability and functions.
In line with this idea, ectopic expression of Foxo1AAA, which is insensitive to
phosphorylation downstream of AKT-mTORC2, seems to alleviate several Pten-deficient
Treg cell phenotypes, it failed to rectify the higher frequency of Treg cells. This
demonstrates that additional and alternative downstream targets might regulate Treg cell
programming. We note that the loss of Treg cell stability also results from Treg cellspecific deletion of neuropilin-1 and Foxo1 (Delgoffe et al., 2013; Ouyang et al., 2012),
although the cellular phenotypes and effects on immune homeostasis are rather distinct
from the Ptenfl/flFoxp3-Cre model. Since the effects on TFH and humoral responses in the
other genetic models have not been described, further work is required to explore the
crosstalk between these molecular pathways in Treg cells.
Briefly, studying the downstream signaling pathway Foxo1 further to expand its
role during the loss of PTEN in Treg cells would provide valuable insights regarding
production of autoantibodies, programming of TFH and TFR cells and Treg metabolism.
Additional studies would include dissecting mechanistic role of PTEN in controlling TH1
responses and TFR cells, if and how mTOR or PI3K inhibitors would restore function and
stability in PTEN-deficient Treg cells. Furthermore, examination of additional pathways
such as SGK1, an enzyme downstream of mTORC2 that promotes Foxo1
phosphorylation, would be insightful.
In summary, our study has unveiled the interplay between the PTEN-mTORC2
signaling axis and the transcriptional and metabolic regulation in Treg cells as a new
mechanism for maintaining Treg cell stability and regulating Treg cell-mediated
repression of TH1 and TFH responses. Given the potent effects of selective Pten deficiency
in Treg cells on immune tolerance and tissue homeostasis, the identification of this
signaling axis provides a new target for therapeutic intervention of systemic autoimmune
and lymphoproliferative diseases.
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APPENDIX. TSC1 PROMOTES THE DIFFERENTIATION OF MEMORY CD8+
T CELLS VIA ORCHESTRATING THE TRANSCRIPTIONAL AND
METABOLIC PROGRAMS*
Introduction
Memory CD8+ T cells play an important role in protective immunity and have the
capability to mount robust recall responses upon reexposure to tumor or pathogenderived antigens. Recent studies have revealed developmental pathways and
transcriptional programs important for the generation of long-lived memory cells (Kaech
and Cui, 2012). Antigen-activated CD8+ T cells rapidly expand and generate
heterogeneous populations of effector cells, namely short-lived effector cells (SLECs)
and memory-precursor effector cells (MPECs) (Joshi et al., 2007; Sarkar et al., 2008).
SLECs (CD127loKLRG1hi) exhibit strong cytotoxicity with high expression of perforin
and granzymes and are predisposed to cell death, whereas MPECs (CD127hiKLRG1lo)
display the increased potential to survive and further differentiate into mature memory
CD8+ T cells. The fate decision between SLECs and MPECs is important for effector
functions and memory differentiation and is shaped by a number of transcription factors.
For instance, transcription factors Eomes and Bcl6 promote the generation of MPECs,
whereas Blimp1 and T-bet drive the transcriptional programs for SLEC differentiation
(Kaech and Cui, 2012).
T cells dynamically reprogram cellular metabolism to fulfill the bioenergetics and
biosynthetic requirements for their survival, proliferation, and differentiation (MacIver et
al., 2013a; Pearce et al., 2013; Wang and Green, 2012). Naïve and memory T cells use
catabolic metabolism via oxidative phosphorylation, especially fatty acid oxidation, to
produce ATP for their survival. In contrast, antigen-stimulated T cells switch to
anabolism to support their rapid proliferation through up-regulating expression of genes
involved in multiple metabolic pathways, including glycolysis, fatty acid and cholesterol
biosynthesis, and amino acid transport (Kidani et al., 2013; Sinclair et al., 2013; Wang et
al., 2011; Yang et al., 2013). Emerging studies indicate that distinct metabolic pathways
contribute to the fate decisions of effector and memory T cells. For instance, the
increased glycolytic metabolism promotes effector T-cell generation (Sukumar et al.,
2013), whereas oxidative phosphorylation and mitochondrial spare respiratory capacity
facilitate memory T-cell differentiation (Pearce et al., 2009; van der Windt et al., 2012).
Recent studies have also identified transcriptional regulators of cell metabolism that
promote effector T-cell differentiation, including HIF1 and IRF4 (Doedens et al., 2013;
Finlay et al., 2012; Man et al., 2013; Yao et al., 2013). In contrast, how cell metabolism
-----------------------*Appendix reprinted with permission Shrestha, S., et al. (2014). "Tsc1 promotes the
differentiation of memory CD8+ T cells via orchestrating the transcriptional and
metabolic programs." Proceedings of the National Academy of Sciences of the United
States of America 111(41): 14858-14863.
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is regulated by immune signaling pathways in effector and memory T-cell differentiation
remains unclear.
mTOR signaling has been implicated in the control of effector and memory T-cell
differentiation (Araki et al., 2009; Li et al., 2011; Rao et al., 2010). Inhibition of mTOR
signaling by rapamycin promotes the generation of MPECs and their subsequent
differentiation into memory T cells upon acute lymphocytic choriomeningitis virus
(LCMV) infection (Araki et al., 2009). In vitro treatment of effector cells with rapamycin
also enhances the developmental potential of memory cells through increasing the
expression of Eomes at the expense of T-bet (Rao et al., 2010). Moreover, rapamycin
enhances the ability of homeostatic proliferation-induced memory CD8+ T cells against
tumor challenge via regulating the expression of Eomes and T-bet (Li et al., 2011).
Despite these studies linking mTOR signaling to the regulation of memory T-cell
differentiation, the upstream regulators of mTOR remain unresolved. Notably, deletion of
Pten does not cause significant defects in memory formation in LCMV infection (Hand et
al., 2010). Moreover, whether mTOR or the canonical activator AKT impacts memory Tcell differentiation via metabolic pathways or other pathways such as cell migration is
unclear (Finlay and Cantrell, 2011). Of note, AKT regulates the differentiation and
function of effector CD8+ T cells via orchestrating the transcriptional program instead of
cellular metabolism (Macintyre et al., 2011). Therefore, the upstream and downstream
mechanisms for mTOR-dependent regulation of memory generation remain to be
defined.
Tuberous sclerosis 1 (TSC1), a negative regulator of mTORC1 signaling
(Laplante and Sabatini, 2012), has been implicated in T-cell homeostasis and anergy
(O'Brien et al., 2011; Wu et al., 2011; Xie et al., 2012; Yang et al., 2011). We and others
have demonstrated that deletion of Tsc1 in naïve T cells disrupts their quiescence and
survival and dampens T-cell–mediated primary responses to bacterial infection (O'Brien
et al., 2011; Wu et al., 2011; Yang et al., 2011). Additionally, Pollizzi et al. has recently
shown the importance of Tsc2, the gene encoding TSC2 that forms heterodimer with
TSC1, in CD8+ T cell programming. Specific deletion of Tsc2 in CD8+ T cells by using
Cd4-Cre mice resulted in terminal differentiation of effector cells, which demonstrated
increased glycolytic activity and were unable to undergo further programming into the
memory phase (Pollizzi et al., 2015). To circumvent the crucial requirement of TSC1 in
naïve T-cell homeostasis, we developed a mouse model to specifically delete Tsc1 in
antigen-experienced CD8+ T cells. We describe here that TSC1 plays a critical role in
promoting the differentiation and function of memory CD8+ T cells in Listeria
monocytogenes (LM) infection. In contrast to the deletion of Tsc1 in naïve T cells, mice
with Tsc1 deficiency in antigen-experienced CD8+ T cells retained normal effector
responses but were markedly impaired in the recall response to antigen reexposure.
Mechanistically, Tsc1 deficiency diminished the generation of MPECs while promoting
the development of SLECs in a cell-intrinsic manner. The functional genomic analysis
indicated that TSC1 coordinated gene expression programs underlying immune function,
transcriptional regulation, and cell metabolism. Furthermore, Tsc1 deletion led to
excessive mTORC1 activity and dysregulated metabolism, including glycolysis and
oxidative phosphorylation, in response to IL-15 stimulation. These findings establish a
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previously unappreciated role of TSC1 in linking immune signaling and cell metabolism
to orchestrate memory CD8+ T-cell development and function.
Results
Tsc1-deficient T cells mount normal effector responses but are impaired to
transition into memory cells
TSC1 is essential to maintain the quiescence of naïve T cells. T-cell–specific
deletion of Tsc1 in mice via Cd4–Cre impairs naïve T-cell survival, homeostasis, and
primary immune responses (O'Brien et al., 2011; Wu et al., 2011; Yang et al., 2011).
Hence, this mouse model impedes the investigation of TSC1 functions in antigen-specific
effector and memory responses. To this end, we crossed mice carrying the floxed Tsc1
alleles (Tsc1fl/fl) with those expressing the Cre recombinase under control of the
Granzyme B promoter (GzmB–Cre) (Jacob and Baltimore, 1999) to specifically delete
Tsc1 in antigen-experienced CD8+ T cells (called “Tsc1−/− mice” here). Under steady
state, Tsc1−/− mice had normal distribution of CD4+ and CD8+ T cells (Figure A-1A).
Homeostasis of these T cells was also undisrupted, as indicated by the normal expression
of CD62L, CD44, and CD127 (Figure A-1B and C), consistent with the absence of Tsc1
deletion in naïve CD8+ T cells (Figure A-1D).
To examine whether Tsc1 deficiency affects effector responses, we challenged
wild-type GzmB-Cre-negative Tsc1fl/fl mice (called “WT mice” here) and Tsc1−/− mice
with L. monocytogenes expressing the chicken ovalbumin (LM–OVA), and assessed
antigen-specific CD8+ T cells in various organs at day 9 postinfection (p.i.), the peak
phase of effector cell expansion. Real-time PCR results showed that Tsc1 genomic DNA
and mRNA were both effectively deleted (Figure A-2A and B). However, the frequency
and number of OVA-specific CD8+ T cells were similar between WT and Tsc1−/− mice in
the various organs examined (Figure A-2C). Also, Tsc1−/− effector cells in the spleen and
liver showed slightly increased proliferation and largely normal death, as indicated by
BrdU incorporation and active caspase-3 staining, respectively (Figure A-2D and E). To
measure the ability of antigen-specific CD8+ T cells to produce cytokines, we
restimulated splenocytes from infected mice with the OVA257–264 [comprised of amino
acids Ser-Ile-Ile-Asn-Phe-Glu-Lys-Leu (SIINFEKL)] peptide ex vivo. WT and Tsc1−/−
splenocytes had similar frequency and number of antigen-specific T cells producing IFNγ and TNF-α (Figure A-2F). Thus, loss of TSC1 in antigen-experienced CD8+ T cells
does not significantly affect effector responses.
After the rapid expansion of antigen-experienced CD8+ T cells, the majority of
effector cells undergo cell death, whereas only a small subset survives and differentiates
into memory cells (Kaech and Cui, 2012). We investigated whether Tsc1 deficiency
impairs the transition from effector to memory T cells by following the dynamics of
OVA-specific T cells in the blood of WT and Tsc1−/− mice infected with LM–OVA. After
clonal expansion, OVA-specific T cells in WT mice underwent the contraction phase,
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Figure A-1. Normal homeostasis of CD4+ and CD8+ T cells in Tsc1−/− mice under
steady state.
(A) Flow cytometry of conventional T cells in the spleen, peripheral lymph nodes
(PLNs), liver, and bone marrow (BM) from WT and Tsc1−/− mice. (B) Expression of
CD62L and CD44 (Left) and the frequency (Center) and number (Right) of naïve CD4+
and CD8+ (CD62LhiCD44lo) T cells. (C) Expression of CD127 on CD8+ T cells from WT
and Tsc1−/− mice. (D) Real-time PCR analysis of Tsc1 mRNA expression in naïve CD8+
(CD62LhiCD44lo) T cells from WT and Tsc1−/− mice. Data are representative of two
independent experiments and are presented as the mean ± SEM.
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Figure A-2. TSC1 deficiency does not impact the effector response of CD8+ T cells.
WT and Tsc1−/− mice were infected with LM–OVA and analyzed at day 9 p.i. (A and B)
Real-time PCR analysis of Tsc1 gDNA (A) and mRNA expression (B) in Kb -OVA+
CD8+ T cells at day 9 p.i. (C) Representative flow cytometry plots of CD8+ T cells (Left)
and the frequency (Center) and number (Right) of Kb-OVA+ CD8+ T cells. (D) BrdU
staining of Kb-OVA+ CD8+ T cells in the spleen and liver of WT and Tsc1−/− mice at day
9 p.i. (Left) and the frequency of BrdU+ cells (Right). (E) Active caspase-3 staining of Kb
-OVA+ CD8+ T cells in the spleen and liver of WT and Tsc1−/− mice at day 9 p.i. (Left)
and the frequency of active caspase-3+ cells (Right). (F) At day 9 p.i., splenocytes from
WT and Tsc1−/− mice were restimulated with the SIINFEKL peptide for intracellular
cytokine staining of IFN-γ and TNF-α. Shown are representative flow cytometry plots of
CD8+ T cells (Left) and the frequency (Center) and number (Right) of IFN-γ+ and TNFα+ CD8+ T cells. Data are representative of two independent experiments (B–F) or one
experiment (A; n = 3 mice per group) and are presented as the mean ± SEM.
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followed by the formation of long-lived memory cells (Figure A-3A). Consistent with
the data described above, the frequency of Tsc1−/− OVA-specific T cells was largely
normal at day 9, but the decline was much greater than that of WT cells (Figure A-3A).
Therefore, loss of TSC1 resulted in a progressive defect in the generation of memory T
cells. To further address this question, we measured OVA-specific T cells in the spleen of
WT and Tsc1−/− mice at different time points. At day 18 p.i., when Tsc1−/− splenocytes
had yet to show significant reduction of antigen-specific CD8+ T cells (Figure A-3B),
these cells already up-regulated caspase-3 activity (Figure A-4A). In contrast, Tsc1−/−
cells showed largely normal proliferation at this stage, as indicated by Ki-67 expression
and BrdU incorporation (Figure A-4B). Moreover, at day 41 p.i., the number of OVAspecific CD8+ T cells was significantly reduced in the spleen and liver of Tsc1−/− mice
(Figure A-3B and C). We next examined cytokine production by memory CD8+ T cells
at day 41 via restimulating splenocytes with the OVA peptide ex vivo. Consistent with the
reduced number of memory CD8+ T cells, Tsc1−/− mice had fewer antigen-specific cells
producing IFN-γ and TNF-α than WT mice (Figure A-3D). Therefore, TSC1 depletion in
antigen-experienced CD8+ T cells impairs the transition from effector responses to
memory formation.
TSC1 deletion impairs the recall response of memory cells
One hallmark of memory T cells is their ability to mount accelerated recall
responses to antigen reexposure. To examine the role of TSC1 in this process, we used
LM–OVA to rechallenge WT and Tsc1−/− mice at day 35 after primary infection. At day 4
after the secondary infection, WT mice mounted robust recall responses in the blood,
spleen, and liver (Figure A-5A). In contrast, the frequency and number of OVA-specific
CD8+ T cells were significantly reduced in Tsc1−/− mice (Figure A-5A). We next
assessed cytokine production of WT and Tsc1−/− splenocytes after restimulation with the
OVA peptide ex vivo. Tsc1−/− mice had reduced frequency and number of T cells
producing IFN-γ and TNF-α compared with WT mice (Figure A-5B). Therefore, Tsc1
deficiency impairs the recall response of memory cells.
One potential caveat of the experimental system above was that the defective
recall response of Tsc1−/− memory T cells could be ascribed to the uneven numbers of
memory T cells in WT and Tsc1−/− mice before rechallenge. To circumvent this
possibility, we sorted OVA-specific memory T cells from WT and Tsc1−/− mice
(CD45.2+) at day 41 p.i. and adoptively transferred equal numbers of WT and Tsc1−/−
memory T cells into naïve recipients (CD45.1+), followed by LM–OVA infection 24 h
later. At day 5 p.i., we assessed the frequency of donor-derived cells in various organs.
The frequency of Tsc1−/− donor cells was significantly reduced compared with that of WT
donor cells in all organs examined (Figure A-5C). We conclude that TSC1 is required
for the recall response of memory cells upon antigen reexposure.
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Figure A-3. The absence of TSC1 diminishes the generation of memory T cells.
(A) The frequency of Kb-OVA+ CD8+ T cells in the blood from WT and Tsc1−/− mice
infected with LM–OVA at the indicated time points was determined by flow cytometry
(*P < 0.05, **P < 0.01). (B) Number of Kb-OVA+ CD8+ T cells in the spleen from WT
and Tsc1−/− mice at days 0, 9, 18, and 41 p.i. (C) Flow cytometry of CD8+ T cells (Left)
and the number of Kb-OVA+ CD8+ T cells (Right) in the spleen and liver from WT and
Tsc1−/− mice at day 41 p.i. (D) Splenocytes from WT and Tsc1−/− mice at day 41 p.i. were
restimulated with the SIINFEKL peptide for intracellular cytokine staining of IFN-γ and
TNF-α. Shown are representative flow cytometry plots of CD8+ T cells (Left) and the
number (Right) of IFN-γ+ and TNF-α+ CD8+ T cells. Data are representative of three
independent experiments and are presented as the mean ± SEM.
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Figure A-4. Proliferation and survival of Tsc1-deficient CD8+ T cells during the
contraction phase.
Flow cytometry of active caspase-3+ (A), Ki -67+ and BrdU+ (B) in Kb-OVA+ CD8+ T
cells in the spleen from WT and Tsc1−/− mice at day 18 p.i. Data are representative of two
independent experiments and are presented as the mean ± SEM.
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Figure A-5. TSC1 deficiency impairs the recall response of memory CD8+ T cells.
(A) WT and Tsc1−/− mice were infected with LM–OVA and rechallenged with LM–OVA
35 d later. The recall response of memory CD8+ T cells was examined at day 4 after
secondary infection. Shown are representative flow cytometry plots of CD8+ T cells
(Left) and the frequency (Center) and number (Right) of Kb-OVA+ CD8+ T cells. (B) At
day 4 after the secondary infection, splenocytes from WT and Tsc1−/− mice were isolated
and restimulated with the SIINFEKL peptide for intracellular cytokine staining of IFN-γ
and TNF-α. Shown are representative flow cytometry plots of CD8+ T cells (Left) and the
frequency (Center) and number (Right) of IFN-γ+ and TNF-α+ CD8+ T cells. (C) Memory
CD8+ T cells (CD45.2+) sorted from WT and Tsc1−/− mice at day 41 p.i. were transferred
into naïve CD45.1+ recipients. At 24 h, the recipients were challenged with LM–OVA
and analyzed 5 d later for CD45.1 and CD45.2 staining of CD8+ T cells (Left) and the
frequency of CD45.2+ donor cells (Right). BM, bone marrow; PLN, peripheral lymph
nodes. Data are representative of two independent experiments and are presented as the
mean ± SEM.
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A cell-intrinsic requirement of TSC1 in memory formation and function
Given the role of TSC1 in the homeostasis of naïve T cells (O'Brien et al., 2011;
Wu et al., 2011; Yang et al., 2011), it remains possible that the T-cell receptor (TCR)
repertoire of Tsc1−/− T cells could be altered and contributed to the defects observed
above. We therefore crossed Tsc1−/− mice onto the TCR-transgenic background (OT-I) in
which CD8+ T cells expressed a SIINFEKL peptide-specific TCR. We mixed
congenically marked naive OT-I and Tsc1−/−OT-I cells at a 1:1 ratio and cotransferred
them to WT recipient mice, followed by LM–OVA infection. This adoptive transfer
system also allowed us to exclude the effects of potential Tsc1 deletion in cells other than
CD8+ T cells. Consistent with the normal effector responses observed in Tsc1−/− mice
(Figure A-2), the frequencies of OT-I and Tsc1−/−OT-I cells were comparable at day 9
p.i. (Figure A-6A). However, at day 29 and 57 p.i., the percentage of Tsc1−/−OT-I cells
was substantially lower than that of OT-I cells (Figure A-6A), indicative of a defect in
the generation of memory cells. Upon LM–OVA rechallenge, the frequencies of
Tsc1−/−OT-I cells were also significantly lower than those of OT-I cells in various organs
examined (Figure A-6B). Moreover, among IFN-γ– or TNF-α–producing cells in the
recipient mice, the majority of them were derived from OT-I instead of Tsc1−/−OT-I
donor cells (Figure A-6C and D). These results establish a cell-intrinsic role of TSC1 in
promoting the formation and function of memory CD8+ T cells.
Impaired differentiation of memory precursors in the absence of TSC1
Aside from rapid expansion, effector cells differentiate into diverse subsets with
distinct potentials for the formation of memory T cells: MPECs (CD127hiKLRG1lo) and
SLECs (CD127loKLGR1hi) (Joshi et al., 2007; Sarkar et al., 2008). To investigate
whether TSC1 deficiency affects the differentiation of MPECs and SLECs, we examined
the expression of CD127 and KLRG1 on WT and Tsc1−/− effector cells at day 9 p.i. We
found that Tsc1−/− OVA-specific CD8+ T cells had markedly reduced frequency and
number of MPECs, whereas the frequency and number of SLECs were increased
(Figure A-7A). Similar findings were observed in Tsc1−/−OT-I T cells in the adoptive
transfer system (Figure A-8A). Moreover, to exclude the potential role of TSC1 in cell
survival (Figure A-4A), we crossed Tsc1−/− mice with mice expressing a Bcl2 transgene
in lymphocytes (labeled as Bcl2-Tg) (Yang et al., 2011). Following LM–OVA infection,
Tsc1−/− Bcl2-Tg T cells showed reduced MPECs but increased SLECs, compared with the
Bcl2-Tg counterparts (Figure A-8B). Taken together, these results reveal an intrinsic
effect of Tsc1 deficiency on the fate decisions between MPECs and SLECs.
The differentiation of activated CD8+ T cells into MPECs and SLECs is
controlled by the differential expression of specific transcription factors, with Eomes and
Bcl6 important in promoting the differentiation of MPECs (Kaech and Cui, 2012). The
expression of these transcription factors in antigen-specific CD8+ T cells from WT and
Tsc1−/− mice at day 9 p.i. was largely comparable (Figure A-9). However, TSC1
deficiency considerably enhanced the expression of Blimp1 and T-bet, which are crucial
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Figure A-6. TSC1 promotes memory CD8+ T-cell generation through cell-intrinsic
mechanisms.
Naïve CD8+ T cells from OT-I+ (CD45.2+) and Tsc1−/−OT-I+ (CD45.1.2+) mice were
isolated, mixed at a 1:1 ratio, and transferred to CD45.1+ recipients, followed by LM–
OVA infection 1 d later. (A) The frequencies of OT-I+ (CD45.2+) and Tsc1−/−OT-I+
(CD45.1.2+) donor T cells out of the total Kb-OVA+ CD8+ cells in the blood at days 9, 29,
and 57 p.i were analysed by flow cytometry. (B–D) At day 57 p.i., mice were
rechallenged with LM–OVA and analyzed 3 d later by flow cytometry. (Right) The
frequencies and numbers of OT-I+ (CD45.2+) and Tsc1−/−OT-I+ (CD45.1.2+) out of the
total Kb-OVA+ CD8+ T cells from the blood, spleen, and liver (B) or out of splenic IFNγ+ (C) or TNF-α+ (D) CD8+ T cells after restimulation with SIINFEKL peptide. Data are
representative of three independent experiments and are presented as the mean ± SEM.
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Figure A-7. TSC1 is required for the differentiation of MPECs.
(A) Flow cytometry of CD127 and KLRG1 (Top) on Kb-OVA+ CD8+ T cells from WT
and Tsc1−/− mice at day 9 p.i., and the frequency (Middle) and number (Bottom) of
MPECs (CD127hiKLRG1lo) and SLECs (CD127loKLRG1hi). (B) Intracellular staining of
Blimp1 and T-bet in splenic Kb-OVA+ CD8+ T cells from WT and Tsc1−/− mice at day 9
p.i. (C) Intracellular staining of Blimp1 and T-bet in MPECs, SLECs, and
CD127hiKLRG1hi cells in splenic Kb-OVA+ CD8+ T cells from WT and Tsc1−/− mice at
day 9 p.i. (D) Flow cytometry of GzmB, CD244, Tim-3, and CTLA-4 at day 9 p.i. in KbOVA+ CD8+ T cells from WT and Tsc1−/− mice. Mean fluorescent intensity (MFI) is
presented above the plots (WT, red; Tsc1−/−, blue; B–D). Data are representative of three
independent experiments and are presented as the mean ± SEM.
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Figure A-8. Intrinsic role of TSC1 in the differentiation of memory precursors.
(A) Naïve CD8+ T cells from OT-I+ (CD45.2+) and Tsc1−/−OT-I+ (CD45.1.2+) mice were
isolated, mixed at a 1:1 ratio, and transferred to CD45.1+ recipients, followed by LM–
OVA infection 1 d later. Flow cytometry of CD127 and KLRG1 expression and
frequencies of memory-precursor effector cells (MPECs) and short-lived effector cells
(SLECs) from OT-I+ (CD45.2+) and Tsc1−/−OT-I+ (CD45.1.2+) donor T cells out of the
total Kb-OVA+ CD8+ T cells at day 7 p.i. (B) Flow cytometry of CD127 and KLRG1 and
frequencies of MPECs and SLECs in Kb-OVA+ CD8+ T cells from Bcl2-transgenic (Tg)
and Tsc1−/− Bcl2-Tg mice at day 8 p.i. Data are representative of two independent
experiments and are presented as the mean ± SEM.
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Figure A-9. Expression of transcription factors implicated in memory T-cell
differentiation.
Intracellular staining of Eomes and Bcl6 in splenic Kb-OVA+ CD8+ T cells from WT and
Tsc1−/− mice at day 9 p.i. Data are representative of three independent experiments.
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factors for the development of SLECs and cytotoxic T-lymphocyte functions (Kaech and
Cui, 2012) (Figure A-7B). The altered expression of Blimp1 and T-bet was observed in
subdivided populations including MPECs, SLECs, and CD127+KLRG1+ cells
(Figure A-7C), highlighting a direct effect of TSC1 deficiency on these transcription
factors. Moreover, Tsc1−/− CD8+ T cells had elevated expression of Granzyme B and
immune inhibitory receptors CD244 (2B4), Tim-3, and CTLA-4 (Blackburn et al., 2009;
Jin et al., 2010; Wherry, 2011) (Figure A-7D). Therefore, consistent with the impaired
memory development and MPEC formation, TSC1 deficiency enhances the expression of
effector-promoting transcription factors Blimp1 and T-bet and multiple immune
inhibitory receptors.
Tsc1-dependent gene expression programs in antigen-specific CD8+ T cells
We performed functional genomics to identify additional pathways controlled by
TSC1 by comparing global gene expression profiles of WT and Tsc1−/− OVA-specific
CD8+ T cells sorted from mice at day 9 p.i. Tsc1−/− cells contained a total of 420
increased probes and 378 decreased probes by greater than 0.5 log2 fold change between
the comparison (Figure A-10A). The heat maps in Figure A-10B showed that Tsc1−/−
CD8+ T cells differentially expressed multiple genes (with log2 fold change > 0.5)
associated with the differentiation of effector and memory CD8+ T cells, including
receptors and secreted factors (Il12rb2, Gzmb, Sell, and IL7r) and transcription factors
(Tcf7, Bach2, and Klf4). Additionally, Tsc1−/− CD8+ T cells had altered expression of
genes involved in various metabolic pathways, including glycolysis (Tpi1), cholesterol
synthesis (Fdps, Hmgcs1, and Insig1), and fatty acid synthesis (Fads1 and Elovl7)
(Figure A-10B). Therefore, TSC1 coordinates the expression of immune response and
metabolic genes in antigen-specific CD8+ T cells.
Given the effects of TSC1 on the differentiation of MPECs and SLECs, it remains
possible that the altered gene profiles of Tsc1−/− cells were simply secondary to the
disrupted ratios of MPECs and SLECs. To address this issue, we compared TSC1dependent targets with the genes differentially expressed in KLRG1hi and KLRG1lo CD8+
T cells in the public database (Hess Michelini et al., 2013). Out of 798 probes with a log2
fold change > 0.5 in Tsc1−/− cells, 621 were matched to this database and were included
for further analysis (Supplementary Data 2 – Tsc1 Datasheet). These TSC1-dependent
targets were partitioned into four distinct clusters that differed in their relationship to the
specific gene targets in KLRG1hi cells (Figure A-10C). A salient feature was that the
majority of TSC1-dependent targets (408 out of 621 probes) fell into cluster 1 (red
circles), in which their expression was comparable between KLRG1hi and KLRG1lo cells
(<0.5 log2 fold change). Further, cluster 2 (blue circles) contained 38 probes that showed
the opposite direction of change in expression, and cluster 3 (green circles) contained 49
probes that were differentially expressed in both types of comparisons, but to a greater
extent in KLRG1hi cells compared with Tsc1−/− cells. Only cluster 4 (yellow circles, 126
probes) contained the target genes with equal magnitude of change (>0.5 log2 fold
change) in both Tsc1−/− and KLRG1hi cells, thus representing concordant changes in both
types of cells. Overall, ~80% of all TSC1-dependent gene targets are independent of
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Figure A-10. TSC1-dependent gene expression profiles in antigen-experienced
CD8+ T cells.
(A) Scatterplot comparison of global gene expression profiles between WT and Tsc1−/−
Kb-OVA+ CD8+ T cells sorted from mice at day 9 p.i.; transcripts with >0.5 log2 fold
change are highlighted (WT, n = 4; Tsc1−/−, n = 5). (B) Heat maps of differentially
expressed genes in Kb-OVA+ CD8+ T cells (with >0.5 log2 fold change), with genes
upregulated or downregulated in Tsc1−/− cells shown in red and blue, respectively. (C)
Comparison of expression changes in Tsc1−/− versus WT cells with those in KLRG1hi
versus KLRG1lo cells. The TSC1-dependent target genes (>0.5 log2 fold change) were
partitioned into four main clusters, shown and colored by regions (R1–R4). Numbers
within parentheses indicate the number of probes within each subregion. (D and E) ROS
production (D) and cell size (E) of splenic Kb-OVA+ CD8+ T cells from WT and Tsc1−/−
mice at day 9 and 18 p.i. Data are representative of one experiment (A–C) and two
independent experiments (D and E) and are presented as the mean ± SEM.
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KLRG1 expression (clusters 1–3), indicating a distinct gene expression program
controlled by TSC1.
We next used the ingenuity pathway analysis (IPA) system to analyze canonical
pathways controlled by TSC1 in activated CD8+ T cells by investigating the differentially
expressed genes with a false discovery rate (FDR) < 0.1. Figure A-11A shows the top 11
canonical pathways affected by Tsc1 deficiency with P < 0.01, including oxidative
phosphorylation and mitochondria dysfunction. Finally, to identify key networks
regulated by TSC1, we did a gene-set enrichment analysis to compare the gene
expression profiles of WT and Tsc1−/− Kb-OVA+ CD8+ cells. This unbiased approach
identified multiple pathways with significant enrichment, including cell cycle, cholesterol
biosynthesis, and oxidative phosphorylation, all of which were up-regulated in Tsc1−/−
CD8+ T cells (Figure A-11B-D).
Given that oxidative phosphorylation was affected by Tsc1 deficiency in both
GSEA and IPA analysis, we examined mitochondrial reactive oxygen species (ROS)
production, which is associated with oxidative phosphorylation (Pearce et al., 2013).
Tsc1−/− CD8+ T cells showed increased ROS production at day 9 and 18 p.i.
(Figure A-10D). Moreover, Tsc1−/− CD8+ cells had larger cell sizes than WT cells
(Figure A-10E), indicative of increased cell growth. Altogether, these data indicate that
TSC1 coordinates diverse pathways involved in immune function, transcriptional
regulation, and cell growth and metabolism.
Dysregulated mTORC1 and metabolic activities in Tsc1-deficient CD8+ T cells
The cytokines IL-2 and IL-15 are critical for the development and maintenance of
CD8+ effector and memory T cells, respectively (Mitchell et al., 2010). To understand
upstream and downstream mechanisms underlying TSC1-dependent memory T-cell
differentiation, we used an in vitro culture system that mimics the programs of effector
and memory T-cell differentiation (van der Windt et al., 2012; Weninger et al., 2001) and
examined the effect of acute deletion of Tsc1 in this system. To this end, we crossed
Tsc1fl/fl with Rosa26–Cre–ERT2 (CreER) and OT-I transgenic mice. We sorted naïve
CD8+ T cells from Tsc1+/+ CreER+ OT-I and Tsc1fl/fl CreER+ OT-I mice and activated
them with OVA and IL-2 in the presence of 4-hydroxytamoxifen (4-OHT) for 4 d,
followed by an additional culture in either IL-2 or IL-15. The deletion of Tsc1 after 4OHT treatment was confirmed by real-time PCR analysis (Figure A-12A), which was
also reflected in the increased cell size (Figure A-12B). IL-2 and IL-15 induce distinct
effects on T-cell growth and metabolic activities (Cornish et al., 2006; van der Windt et
al., 2012), although how these metabolic programs are regulated is poorly defined. We
therefore examined oxygen consumption rate (OCR) and extracellular acidification rate
(ECAR), which denote mitochondria respiration and glycolysis, respectively, in cells
cultured with IL-2 or IL-15. Consistent with previous observations (van der Windt et al.,
2012), IL-15 mediated a stronger effect on OCR than IL-2 did, whereas IL-2 but not IL15 potently elevated ECAR activity (Figure A-13A and B). Importantly, Tsc1 deficiency
markedly enhanced ECAR and OCR in cells cultured with IL-15, but effects were very
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Figure A-11. Dysregulated cell metabolism in Tsc1-deficient T cells.
(A) Ingenuity pathway analysis of canonical pathways controlled by Tsc1 in Kb-OVA+
CD8+ T cells sorted from mice at day 9 p.i. (FDR < 0.1). (B–D) Gene set enrichment
analysis reveals the overrepresentation of signature genes in cell-cycle mitotic (B),
cholesterol biosynthesis (C), and oxidative phosphorylation (D) in TSC1-deficient CD8+
T cells at day 9 p.i. (n = 4–5 mice per genotype). The middle part of the plots shows the
distribution of the genes in each gene set (“Hits”) against the ranked list of genes. The
lists on the left show the top genes in the leading edge subset. NES, normalized
enrichment score.
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Figure A-12. TSC1-dependent effects on cell size and glycolytic activity in activated
Tsc1fl/fl CreER+ OT-I+ cells upon 4-OHT treatment.
Naïve CD8+ T cells from Tsc1+/+ CreER+ OT-I+ (WT) and Tsc1fl/fl CreER+ OT-I+
(Tsc1CreER) mice were stimulated with OVA in the presence of IL-2 and 4-OHT for 4 d,
followed by analysis of Tsc1 mRNA expression (A), cell size (B), and glycolytic activity
after IL-15 stimulation for 24 h in the absence or presence of rapamycin (Rapa) (C). Data
are representative of two independent experiments.
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Figure A-13. TSC1 deficiency leads to dysregulated mTORC1 activity and
metabolism in activated CD8+ T cells.
(A and B) Naïve CD8+ T cells from OT-I+Tsc1+/+ CreER+ (WT) and OT-I+Tsc1fl/fl
CreER+ (Tsc1CreER) mice were stimulated with OVA in the presence of IL-2 and 4-OHT
for 4 d, and live cells were isolated and cultured with IL-15 or IL-2 for 5 d. OCR and
ECAR were measured in IL-15 (A) and IL-2–cultured cells (B). (C) Phosphorylation of
S6 in WT and Tsc1CreER cells activated with OVA and then stimulated with IL-2 or IL-15
for 18 h. Numbers below lanes indicate band intensity relative to that of β-actin (loading
control). (D) Flow cytometry of S6 phosphorylation in WT and Tsc1CreER cells activated
with OVA and then stimulated with IL-15 for 1 and 2 d in the absence or presence of
rapamycin (Rapa). (E and F) OCR (E) and ECAR (F) of WT and Tsc1CreER cells
activated with OVA and then stimulated with IL-15 for 24 h in the absence or presence of
rapamycin. (G and H) Flow cytometry of CD62L, Bcl2 (G), and caspase-3 activity (H) in
WT and Tsc1CreER cells activated with OVA and then stimulated with IL-15 for 2–3 d in
the absence or presence of rapamycin. Data are representative of three independent
experiments and are presented as the mean ± SEM.
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modest in cells cultured with IL-2 (Figure A-13A and B). Thus, Tsc1 deletion results in
dysregulated metabolic activity during IL-15–mediated differentiation of memory T cells.
Moreover, compared with Tsc1-sufficient controls, Tsc1-deficient T cells upregulated mTORC1 activity, as indicated by the increased phosphorylation of the
ribosomal protein S6. Notably, the extent of up-regulation over control cells was much
more profound in IL-15–stimulated conditions (~7.5-fold) compared with IL-2–
stimulated conditions (~2.5-fold) (Figure A-13C). Furthermore, treatment of IL-15–
stimulated cells with rapamycin considerably blocked the dysregulated mTORC1
(Figure A-13D), OCR (Figure A-13E), and ECAR activities (Figure A-13F), as well as
T-cell glycolytic activity (Figure A-12C). Therefore, excessive mTORC1 activation in
the absence of TSC1 drives the metabolic dysregulation. Moreover, compared with IL-2,
IL-15 has more of a stringent requirement for TSC1 functions in actively suppressing
mTORC1 and mTORC1-dependent metabolic activities.
Associated with dysregulated metabolism, Tsc1-deficient cells down-regulated
CD62L and Bcl2 expression (Figure A-13G) but up-regulated caspase-3 activity
(Figure A-13H). Importantly, rapamycin treatment restored the excessive activity of
mTORC1 and the dysregulated expression of CD62L, Bcl2, and caspase-3 activity
(Figure A-13G and H). Therefore, TSC1 links mTORC1 activation, cell metabolism, and
immune regulation.
Discussion
In this study, we reveal an important function of TSC1 in promoting the
differentiation and function of memory CD8+ T cells in bacterial infection. By
developing a mouse model to ablate Tsc1 specifically in antigen-experienced CD8+ T
cells, we found that TSC1 is dispensable for effector responses at the expansion phase,
but is essential for the formation of memory CD8+ T cells and their recall responses to
antigen reexposure in a T-cell–intrinsic manner. Mechanistically, deficiency of TSC1
dampens the differentiation of MPECs, associated with the impaired transcriptional and
metabolic programs. In particular, loss of TSC1 results in excessive mTORC1 activity
and dysregulated glycolytic and oxidative metabolism in response to IL-15 stimulation.
These findings provide new mechanistic insight into T-cell memory formation and
function and highlight that modulation of TSC1 function is a potential strategy to
improve the quality and quantity of memory responses.
Emerging studies highlight a pivotal role of mTOR signaling in the fate decisions
of effector and memory T cells (Araki et al., 2009; Hand et al., 2010; Li et al., 2011; Rao
et al., 2010), but the upstream regulators of mTOR remain unresolved. Notably, mTOR
can be activated by AKT-independent pathways in effector CD8+ T cells (Finlay et al.,
2012; Macintyre et al., 2011), and deletion of Pten does not cause significant defects in
memory formation (Hand et al., 2010). Here, we circumvented the requirements of
mTOR signaling in naïve T-cell homeostasis (O'Brien et al., 2011; Wu et al., 2011; Yang
et al., 2011) and immediate TCR activation (Yang et al., 2013), by specific ablation of
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Tsc1 in antigen-experienced CD8+ T cells. Although Tsc1 deficiency elevates mTORC1
activity, this does not significantly impact the generation of effector CD8+ T cells at the
peak phase of primary responses. Instead, TSC1 function is essential to ensure proper
differentiation between MPECs and SLECs, which is a prerequisite for the subsequent
generation of memory T cells (Kaech and Cui, 2012). Specifically, Tsc1 deficiency
suppresses the formation of MPECs and reciprocally promotes the formation of SLECs.
These effects were observed in multiple independent systems including direct challenge,
adoptive transfer of OT-I cells, and Bcl2-Tg backgrounds, thereby highlighting a direct
role of TSC1 in cell fate decisions. Accordingly, Tsc1-deficient antigen-specific CD8+ T
cells have increased expression of Blimp1 and T-bet, which likely suppress the function
of transcription factors required for memory differentiation (Kaech and Cui, 2012).
Additionally, Tsc1 deletion up-regulates inhibitory receptors associated with T-cell
exhaustion (Blackburn et al., 2009; Jin et al., 2010; Wherry, 2011). Moreover, Tsc1
deficiency impairs the expression of genes involved in T-cell trafficking, such as Lselectin (encoded by Sell) and CCR7, which are required for the migration to centralmemory T cells in the T-cell areas of secondary lymphoid organs (Finlay and Cantrell,
2011). These results indicate that TSC1 promotes memory T-cell responses, in part, by
impinging upon the transcriptional programs required for memory precursor
differentiation.
Metabolic programs are dynamically regulated to match the differentiation and
function of T cells (MacIver et al., 2013; Pearce et al., 2013; Wang and Green, 2012). For
the fate decisions between effector and memory CD8+ T cells, glycolytic and lipid
synthetic metabolism promote effector T-cell generation (Kidani et al., 2013; Sukumar et
al., 2013), whereas oxidative phosphorylation and mitochondrial activity facilitate
memory development (Pearce et al., 2009; van der Windt et al., 2012). From the
microarray and bioinformatics analyses, we found that Tsc1−/− antigen-specific CD8+ T
cells exhibit elevated expression of metabolic genes involved in glycolysis, lipid
synthesis, and oxidative phosphorylation. Moreover, Tsc1-deficient T cells show
enhanced glycolytic and oxidative phosphorylation rates in vitro that are closely linked
with IL-15–mediated signaling. Although the increased glycolysis upon Tsc1 deletion is
in agreement with impaired development of memory cells (Sukumar et al., 2013), the
effect of the increased oxidative phosphorylation remains to be established. Notably, the
IPA analysis indicates that Tsc1 deficiency impinges upon both oxidative
phosphorylation and mitochondria function. Further, loss of TSC1 results in excessive
production of mitochondrial ROS. These findings indicate that TSC1 functions to ensure
proper regulation of the metabolic programs, the disruption of which may contribute to
impaired memory T-cell differentiation.
A recent study investigated the role of TSC2 in CD8+ T cell function. T cellspecific deletion of Tsc2 (referred to as Tsc2-/-) increased glycolytic activity in CD8+ T
cells, and Tsc2-deficient CD8+ T cells were unable to differentiate into memory CD8+ T
cells (Pollizzi et al., 2015). However, differences in terms of effector function exist in
between Tsc1−/− and Tsc2−/− mice. The potential mechanism for this difference might due
to cell death processes, as Bcl2 expression and activation-induced cell death are not
affected in Tsc2−/− mice, unlike Tsc1−/− mice. Additionally, presence mTORC2 activity in
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Tsc2−/− mice resulted in potent effector CD8+ T cell function that was reduced in Tsc1−/−
mice (O'Brien et al., 2011; Pollizzi et al., 2015; Wu et al., 2011; Yang et al., 2011).
We and others have previously demonstrated a key role of TSC1 in the
establishment of naïve T-cell quiescence (O'Brien et al., 2011; Wu et al., 2011; Yang et
al., 2011). Although the exit from quiescence in response to TCR stimulation is essential
for proper T-cell activation and effector responses (Yang et al., 2013), how memory T
cells reestablish a quiescent state is unclear. The increased cell size and dysregulated
metabolic activities of Tsc1-deficient T cells are consistent with an impaired quiescence
state of memory T cells. Additionally, gene expression profiling indicated that Tsc1deficient CD8+ T cells down-regulate the expression of transcription factors required for
the maintenance of cell quiescence including Bach2 and KLF4 (Roychoudhuri et al.,
2013; Tsukumo et al., 2013; Yamada et al., 2009). Therefore, the failure to reestablish
quiescence in Tsc1-deficient memory T cells is the likely basis for their poor recall
responses to antigen rechallenge. This is reminiscent of the observation that abrogated
quiescence of naïve T cells is associated with the defective initiation of primary immune
responses (Yang et al., 2011).
In summary, TSC1 functions as a critical controller of the generation and function
of memory T cells. TSC1 regulates the formation of memory T cells through shaping the
fate decisions between MPECs and SLECs and by orchestrating the transcriptional and
metabolic programs. Modulation of TSC1 functions in T cells represents a potential
strategy to enhance the quantity and quality of memory T cells against infections and
tumors.
Experimental Procedures
Mice
Tsc1fl/fl, CD45.1 and T-cell receptor-transgenic OT-1 mice were purchased from
the Jackson Laboratory. Rosa26-Cre-ERT2 (CreER) mice have been described previously
(Yang et al., 2011). GzmB-Cre mice were kindly provided by Drs. J. Jacob and M. Li. All
mice were backcrossed to the C57BL/6 background for at least 8 generations. Animal
protocols were approved by the Institutional Animal Care and Use Committee of St. Jude
Children’s Research Hospital.
Listeria monocytogenes infection
For the study of primary immune response, mice were intravenously infected with
3 × 104 colony-forming units (CFU) of LM-OVA. For the analysis of secondary immune
response, mice were rechallenged with 5 × 104 CFU of LM-OVA at day 35 or more after
primary infection. The recall responses were determined 4-6 days after the secondary
infection.
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Flow cytometry
For analysis of surface markers, cells were stained in PBS containing 2% (wt/vol)
BSA, with anti-CD4 (RM4-5), anti-CD8α (53-6.7), anti-TCRβ (H57-597), anti-CD44
(1M7), anti-CD62L (MEL-14), anti-KLRG1 (2F1), anti-CD127 (A7R34), anti-CD45.1
(A20), anti-CD45.2 (104), anti-CD244.2 (eBio244F4) (eBioscience) and Tim-3 (215008)
(R&D Systems). OVA peptide (SIINFEKL)-loaded mouse H-2Kb tetramer was from
Baylor Tetramer Production Facility. BrdU labeling and active caspase-3 staining were
performed according to the manufacturer’s instructions (BD Biosciences). For
intracellular staining, anti-Eomes (Dan11mag) and anti-Ki-67 (20Raj1) were purchased
from eBioscience, anti-T-bet (4B10) and anti-Gzmb (GB11) from Biolegend, anti-Bcl2
(N46-467) from BD Biosciences, and anti-Blimp-1 (3H2-E8) from Thermo Scientific.
For intracellular cytokine staining, CD8+ T cells were stimulated for 5 hours with
OVA257–264 (SIINFEKL) in the presence of monensin before being stained according
to the manufacturer's instructions (BD Biosciences). ROS production was measured by
incubating T cells for 30 min at 37°C with 10 μM CM-H2DCFDA (5-(and-6)chloromethyl-2,7-dichlorodihydrofluorescein diacetate acetyl ester; Invitrogen) after
staining of surface markers. Staining with antibodies to S6 phosphorylated at Ser235 and
Ser236 (D57.2.2E; Cell Signaling Technology) was done after fixing cells with Phospho
Lyse/Fix Buffer, followed by permeabilization with Phosflow Perm Buffer III (BD
Biosciences). Flow cytometry data were acquired on an LSRII or LSR Fortessa (BD
Biosciences) and analyzed with FlowJo software (TreeStar).
Cell purification and culture
Sorted naïve T cells (CD8+CD62LhiCD44lo) from OT-1+ Tsc1+/+ CreER+ and OT1 Tsc1fl/fl CreER+ mice were cultured in vitro in Click's medium (plus βmercaptoethanol) supplemented with 10% (vol/vol) FBS and 1% (vol/vol) penicillinstreptomycin and stimulated with 10 μg/ml SIINFEKL peptide and 100 U/ml IL-2 for 4
days in the presence of 0.5 μM 4-OHT. Ficoll-purified live CD8+ T cells were then
stimulated with IL-15 (50 ng/ml) or IL-2 (50 U/ml) in the presence or absence of
rapamycin (50 nM).
+

Cell isolation and adoptive transfer
For adoptive transfer, naïve CD8+ T cells from OT-I+ (CD45.2+) and Tsc1−/− OTI (CD45.1.2+) were transferred to CD45.1+ recipients. One day after transfer, mice were
infected with 3 × 104 cfu of LM–OVA for the primary response and 5 × 104 CFU of LM–
OVA for the recall response. OVA+ CD8+ T cells were sorted from the spleen of WT or
Tsc1−/− mice (CD45.2+) at day 41 p.i. and transferred into congenically marked
(CD45.1+) recipients. One day after the transfer, mice were infected with 5 × 104 CFU of
LM–OVA and used for the analysis of secondary CD8+ T-cell responses at days 4–6.
+
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Metabolic assay
The bioenergetic activities of the extracellular acidification rate and oxygen
consumption rate pathways were measured using the Seahorse XF24-3 Extracellular Flux
Analyzer per the manufacturer’s instructions (Seahorse Bioscience). The glycolytic flux
assay was determined by measuring the detritiation of [3-3 H]-glucose, as described (Shi
et al., 2011).
Gene expression profiling by microarray analysis
RNA samples from freshly isolated OVA+ CD8+ cells from WT (n = 4 after the
exclusion of one sample due to abnormal Gapdh 3'/5' ratio and based on principal
component analysis) and Tsc1−/− mice (n = 5) were analyzed with the Affymetrix HT
MG-430 PM GeneTitan peg array, and expression signals were summarized with the
robust multi-array average algorithm (Affymetrix Expression Console v1.1). Lists of
differentially expressed genes by ANOVA (FDR < 0.1) were analyzed for functional
enrichment using the Ingenuity Pathways (www.ingenuity.com). GSEA within canonical
pathways was performed as described (Subramanian et al., 2005).
RNA, genomic DNA, and immunoblot analyses
Real-time PCR analysis was performed with primers and probe sets from Applied
Biosystems, as described (Liu et al., 2009). Genomic DNA (gDNA) was purified from
the sorted naïve CD8+ (CD8+CD62LhiCD44lo) T cells using a DNeasy blood and tissue
kit from Qiagen. Tsc1 gDNA was quantified by real-time PCR normalizing with nuclear
intron of β-globin gDNA with the following primers: Tsc1 forward 5′GTCACGACCGTAGGAGAAGC-3′, Tsc1 reverse 5′-GAATCAACCCCACAGAGCAT3′, and β-globin forward 5′-GAAGCGATTCTAGGGAGCAG-3′, β-globin reverse 5′GGAGCAGCGATTCTGAGTAGA-3′. Immunoblots were performed as described
previously (Liu et al., 2010), using the following antibodies: p-S6 (2F9; Cell Signaling
Technology) and β-actin (AC-15; Sigma).
Statistical analysis
P values were calculated with Student’s t-test (GraphPad Prism). P values of less
than 0.05 were considered significant. All error bars represent the SEM.
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